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1. Introduction 
1.1 Aim of the study 
The frequency of opportunistic fungal infections has considerably increased in the last 
20 years and they currently represent a global health problem [2]. This increasing 
incidence of fungal infection is directly related to the growing number of 
immunocompromised individuals, resulting from medical advances in healthcare, such 
as the introduction of newer methods for hematopoietic stem cell transplantation, the 
evolution of organ transplantation practices, and the use of novel immunosuppressive 
agents [3]. 
An epidemiological study in the United States showed that the number of sepsis 
cases caused by fungal organisms increased by 207 % between 1979 and 2000 [4]. In 
the United States, the incidence of bloodstream infections varies between 0.28 to 0.96 
per 1.000 patients admissions, and 0.2 to 0.38 in Europe, whereas in Latin America 
these rates vary between 1.2 and 5.3 [5]. 
The most frequently diagnosed fungal infections are caused by Candida 
albicans, Cryptococcus neoformans, and Aspergillus fumigatus. These pathogens can 
cause skin and mucous membrane infections or invasive fungal infections, particularly 
in immunocompromised patients. In these patients, invasive fungal infections are often 
associated with high morbidity and mortality [6, 7]. 
Fungal infections are difficult to treat successfully. The number of antifungal 
agents available to treat this kind of infections is limited. In fact, it took 30 years for the 
newest class of antifungal drugs, the echinocandins, to progress from bench-to-beside. 
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and they are the newest class of antifungal agents available since 2001 [8]. The gold 
standard therapy for many invasive fungal infections is amphotericin B (AmB), which 
was discovered nearly 50 years ago. The emergence of antifungal resistance has also 
decreased the efficacy of conventional therapies. In addition, treatments are time-
consuming and thus demanding on health care budgets. Current drugs have only a 
limited spectrum of action and toxicity, and drug interactions are common. 
Furthermore, fungal and mammalian cells share many structures and metabolic 
pathways, limiting the design of drugs that selectively target cells from human hosts [9]. 
For these reasons, effective alternatives are required to treat fungal superficial 
and localized infections, mainly in immunocompromised patients, which are highly 
susceptible to infections, due to their highly compromised immune system. A promising 
alternative is antimicrobial Photodynamic Therapy (aPDT), originally developed for the 
treatment of skin tumors [10]. APDT combines a photoactive molecule, termed 
photosensitizer, light, and oxygen to produce cytotoxic reactive oxygen species (ROS), 
such as singlet oxygen or oxygen radicals, which are able to eliminate pathogens [11]. 
Therefore, the photodynamic action of the new porpyhrine-derivative 
photosensitizer, XF-73 was investigated against both planktonic and biofilm growing C. 
albicans. The efficacy of aPDT was compared to the efficacy of Amphotericin B 
(AmB). Furthermore, the mechanism of action of XF-73-aPDT in C. albicans biofilms 
was investigated. 
The mechanisms of resistance to aPDT are not completely elucidated, and heat 
shock proteins overexpression is a mechanism of resistance, whereby cells could 
develop resistance to aPDT. Therefore, the role of heat shock protein 70 (Hsp70) 
expression by C. albicans was investigated regarding their protecting properties against 
oxidative stress, caused by aPDT. In addition, a new optical sensor technology was used 
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to monitor in a non-invasive manner the oxygen concentration in C. albicans and S. 
epidermidis biofilms during aPDT, which could be a new possibility to improve the 
efficacy of aPDT. In the future, this therapy might either substitute or act as coadjuvant 
in the conventional antimicrobial therapy. 
1.2 History of Antimicrobial Photodynamic Therapy 
Antimicrobial Photodynamic therapy (APDT) was first reported in 1900 by Oskar Raab 
in Munich. He observed that the protozoan Paramecium caudatum was killed after 
staining with acridine orange and subsequent exposure to light under certain 
wavelengths [12]. Additional experiments showed that oxygen was also essential in the 
photodynamic action, because antibacterial activity of fluorescent dyes against the 
facultative anaerobic species Proteus vulgaris could not be demonstrated in the absence 
of oxygen. Fig. 1 shows the results of the first antimicrobial photodynamic experiment 
using the photosensitizer (PS) eosin in combination with sun light to kill Streptococcus 
bacteria. In 1903, H. von Tappeiner and A. Jesionek treated skin tumours with topically 
applied eosin and white light. This phenomenon was coined “photodynamic 
action”[13]. 
With the discovery of antibiotics, starting with penicillin in 1929 followed by the 
golden age of antibiotics, in the 1950’s, when one-half of today’s commonly used drugs 
were discovered, aPDT lost its attention. At this time, many experts believed that the 
problematic with infectious diseases is over. But the widespread and sometimes 
inappropriate use of antibiotics, the use of antibiotics in the food and farming industries 
led all soon to the appearance of antibiotic resistant strains [14]. In fact, resistant strains 
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started to be reported already in 1955, four years after penicillin was available on the 
market [15]. 
To date, approximately 70% of bacteria, which cause hospital acquired 
infections, are resistant to at least one antibiotic used to treat them, and some organisms 
are resistant to all approved antibiotics and can only be treated with experimental and 
potentially toxic drugs [16]. 
 
Fig. 1. First antimicrobial photodynamic experiment (1905) using eosin combined with day 
light to kill streptococci. Adopted from: [17] 
The increasing threat of microbial resistance has highlighted aPDT as a 
promising alternative treatment for localized and superficial infections [18]. Currently, 
in many countries aPDT is an approved additional therapy for the treatment of 
periodontal disease, dental infections and infected leg ulcers. In the future, it has the 
potential to become the standard therapy for infectious localized and superficial 
diseases. In this way, effective systemic agents can be withheld for more life-
threatening infections. 
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1.2.1 Mechanism of action 
After a photosensitizer (PS) absorbs a photon of light of an appropriate wavelength, this 
molecule will be promoted from its ground state to the excited singlet state, which is 
short lived with a half-life between 10-6 and 10-9 s [19, 20]. Then, the PS can return to 
the ground state, by emitting a photon as light energy (fluorescence) or heat. 
Alternatively, the molecule may convert via intersystem crossing (ISC) to the triplet 
state. The triplet state PS has lower energy than the singlet state, but it has a longer 
lifetime (10–3 s). The PS in the triplet state can return to the ground state by a 
phosphorescence process (P) or interact with oxygen by two mechanisms: (Fig. 2). 
In the type I mechanism: the triplet state PS can transfer electrons to 
surrounding biomolecules producing radicals, like superoxide anions (O2-) and hydroxyl 
radical (HO*). These radicals can further react with oxygen to generate hydrogen 
peroxide (H2O2). All of them are able to attack cellular targets [21, 22]. In type II 
mechanism there is a transfer of energy from the excited triplet state PS to the oxygen, 
producing the electronically excited and highly reactive singlet oxygen (1O2), which is 
able to react to cell membranes, peptides, and nucleic acids (Fig. 2) [23]. However, 
DNA damage seems not to be the main cause of cell death, since Deinococcus 
radiodurans, which is known to have a very efficient DNA repair mechanism, is readily 
killed by the photodynamic process [24]. The photodynamic mechanism damages 
fungal cells by generation of reactive oxygen species (ROS), which can perforate cell 
walls and membranes. Furthermore, when the PS is taken up intracellularly, ROS 
generated by light excitation induce photodamage to internal cell organelles. All these 
oxidizing processes lead to a final cell death [21, 25]. 
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Fig. 2: Schematic illustration of mechanism of action of aPDT: Generation of ROS can 
follow two alternative pathways after light activation by a given PS. Upon absorption (A) 
of a photon by the ground state PS, the excited state of the PS is formed. The excited state 
is short-lived and can undergo intersystem crossing (ISC) to a long-lived triplet state or, 
alternatively, can return to the ground state by fluorescence emission (F) or heat (H) or 
both. In the triplet state the PS can return to the ground state by phosphorescence (P) or 
interact with oxygen by two mechanisms: Type I: Generation of superoxide anions (O2-), 
hydroxyl radical (HO*) and hydrogen peroxide (H2O2) by charge transfer from the excited 
PS. Type II: The triplet state of PS can directly undergo energy exchange with triplet 
ground state oxygen, leading to the formation of singlet oxygen, 1O2. The generated ROS 
rapidly react with their environment, depending on the localization of the excited PS: 
microorganism walls, lipid membranes, peptides, and nucleic acids. 
1.2.2 Susceptibility of pathogens to aPDT 
Differences in the cell wall structure and cell size account for the different pattern of 
susceptibility to aPDT between different microbial cells, like bacteria and fungi (Fig. 3). 
Cationic PSs are the predominant type of all current PS employed in aPDT. The 
mechanism of action of positive charged PSs may be the “self-promoted uptake 
pathway”, where the cationic molecules displace the divalent cations, Ca2+ and Mg2+ on 
the outer membrane and bind to lipopolysaccharides (LPS), increasing the permeability 
of the outer membrane to cationic PSs [11, 26]. 
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The cytoplasmic membrane of Gram-positive bacteria is surrounded by an outer 
wall composed of peptydoglican, lipoteichoic and teichoic acids, with no significant 
amount of lipids or proteins. This peptidoglycan network is thick but relatively porous, 
allowing photosensitizer, independently of their charge, to cross (Fig. 3 A). In contrast, 
the outer layer of Gram-negative bacteria is a highly complex multilayered structure, 
consisting of a periplasmic space, containing enzymes and other components, a few 
layers of peptidoglycan and an additional lipid membrane, containing strongly 
negatively charged lipopolysaccharides (LPS), lipo-proteins and proteins with porin 
function (Fig. 3 B). Thus, the outer layer of Gram-negative bacteria represents a very 
effective permeability barrier between the cell and its environment, tending to restrict 
the binding and penetration of many photosensitizer structures. The efficacy of aPDT 
against Gram-negative bacteria can be increased by the addition of biological or 
chemical molecules, e.g. polymyxin B or Ethylenediaminetetraacetic acid (EDTA), 
which are known to be membrane disrupting agents [27]. 
Cells of fungi like C. albicans are even more resistant to aPDT than Gram-
positive and Gram-negative bacteria (Fig. 3 C). They are enveloped by a thick cell wall, 
composed of glucan, mannan, and chitin and have a nuclear membrane, protecting the 
nucleus and acting as a barrier either to the penetration of photosensitizers or the 
reactive oxygen species formed during the treatment. The presence of nuclear membrane 
also restricts the mutagenic potential from aPDT. Besides, fungal cells are larger than 
bacterial cells, presenting more targets to be damaged; consequently the amount of 
reactive oxygen species necessary to kill yeasts is much greater than the amount 
necessary to kill bacteria [1, 28]. 
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Fig. 3. Cell wall of A) Gram-positive bacteria, B) Gram-negative bacteria and C) fungal 
cells. Modified from reference [29] 
1.2.3 Irradiation parameters 
To achieve maximum treatment efficacy, one of the most important factors concerning 
the choice of the light source is that the emission spectrum of the used light source 
matches the absorption spectra of the PS used. In addition, sufficient light intensity 
should be delivered at the site where the PS-loaded pathogen is localized, like the skin 
or mucosal surfaces. Light of longer wavelength (>500 nm) have a deeper penetration in 
biological tissues. Therefore, it is important to find an agreement with regard to the 
penetration depth of light, the absorption spectrum of the PS used, and the location sites 
of the pathogen [30]. 
40-80 nm
lipoteichoic acid
teichuronic acid
cytoplasm membrane
peptidoglycan
10-15 nm
lipopolysaccaride
porin
lipoproteins
peptidoglycan
periplasmic space
cytoplasm membrane
~110 nm
cytoplasm membrane
manoproteins
β -1,6-glucan
β -1,3-glucan+chitin
manoproteins
ß-glucan synthase
A 
B 
C 
1 Introduction 9 
 
Irradiation parameters depend on the application of interest. Decolonization of 
microorganisms growing on the surface of the skin, affecting just the stratum corneum, will 
be inactivated by blue light (~400 nm). In deeper infections where microorganisms colonize 
the stratum corneum and hair follicles, red light (~600 nm) is necessary. Power outputs for 
light sources in a PDT are usually in the range of 10–100 mW cm-2, with total light 
doses between 10 and 200 J cm-2. One crucial point in light dosimetry is to avoid 
thermal effects by the light itself, when light doses above 100 mW cm-2 are needed for 
an efficient aPDT [21]. 
1.2.4 Photosensitizers 
There are additional criteria that a given PS should fulfill: (I) efficacy against several 
classes of microorganisms at relatively low concentrations and low light fluence, (II) no 
dark toxicity, (III) selectivity for microbial cells over human cells, (IV) hydrophilic 
properties and electric positive charges, due to the penetration in the microbial cell wall, (V) 
high extinction coefficients to efficiently absorb blue or red light and (VI) high triplet 
and singlet oxygen quantum yields [31]. There are several PSs used to photoinactivate 
microbial cells, most of them belonging to three chemical groups: phenothiazines, 
porphyrins and phthalocyanines. 
1.2.4.1 Phenothiazines 
Phenothiazinium dyes have been employed in medical practice for over 100 years [32]. 
As a consequence, the toxicity of these dyes is well documented and they are the only 
PSs clinically used in aPDT so far (Table 1). 
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Table 1. Some antimicrobial photosensitizers available on the market worldwide. Adopted 
from ref: [33] 
Photosensitizer Infections treated Country  Company 
Phenotiazine 
derivatives Periodontal disease Canadá Periowave 
Phenotiazine 
derivatives Dental infection Germany Helbo 
Methylene blue Dental infection Brazil Aptivalux 
Phenotiazine 
derivatives Dental infection UK DenFotex 
Phenotiazine 
derivatives Infected leg ulcers UK Photopharmica 
Phenothiazinium PSs are planar, tricyclic, aromatic molecules, presenting 
intrinsic positive charge and blue color with an intense absorption between 600 and 680 
nm. The most used phenothiazines in aPDT are methylene blue (MB) and Toluidine 
Blue (TBO) (Fig. 4 A and 4 B, respectively). MB has a molecular weight (MW) 319.85 g 
mol-1 and a quantum yield of Φ∆ = 0.52 [34]. It is used in the sterilization of blood 
products, since this PS has a high chemical affinity to the nucleic acids, which denotes 
its potential to application against virus, including HIV, hepatitis B and C [35, 36]. TBO 
has a MW of 305.83 g mol-1. It is predominantly used in the treatment of oral infections, 
for sterilizing dental cavities and root canals, and for treating periodontitis [37]. 
          
Fig. 4. Chemical structure of A) Methylene Blue and B) Toluidine Blue O 
S+
N
N N
CH3
CH3 CH3
CH3
NCH3
NH2 N
+
CH3
S
CH3
A B 
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1.2.4.2 Porphyrins 
Porphyrins are a group of naturally occurring intensely colored compounds, involved in 
a number of biologically important roles, like oxygen transport and photosynthesis, and 
have applications in a number of fields, ranging from fluorescence imaging to medicine. 
They are composed of four pyrrole rings, linked through four methine bridges (Fig. 5) 
[38]. Porphyrins have a strong absorption band around 400 nm (Soret band), but further 
absorption peaks between ~500-700 nm (Q-bands). So, a large number of porphyrins 
derivatives with different side groups have been synthesized, presenting higher 
absorption bands in the far red spectral region [39]. 
 
Fig. 5. Chemical structure of a porphyrin 
1.2.4.3 TMPyP 
TMPyP (5,10,15,20-Tetrakis(1-methyl-4-pyridyl)-21H,23H-porphine, tetra-p-tosylate 
salt) possesses four positive charges on the peripheral pyridinium rings and a molecular 
weight of 682.2 g mol-1 (Fig. 76). It is a well-known PS, which, besides the positive 
charges, has a high singlet oxygen production quantum yield of Φ∆ = 0.77 [40]. 
Furthermore, TMPyP has been shown to be an effective PS against C. albicans 
planktonic cells. These cells underwent 5 log10 decrease inactivation, when incubated 
for 30 min with TMPyP and then irradiated for 30 min with an applied dose light of 90 J 
cm-2 [41]. Photoaction of TMPyP was also tested against C. albicans planktonic cells, 
N
H
N N
N
H
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immobilized on agar surfaces. First of all, cells were treated with TMPyP in solution for 
30 min and then placed on an agar surface. Then cells were illuminated for 30 min (90 J 
cm-2). No colony formation on the agar surface was observed, for cells treated with 5 
µM TMPyP. In the second condition, C. albicans cells were grown as a lawn on the 
agar surface with TMPyP impregnated in a small area. Cultures were kept in the dark 
for 30 min, allowing binding of TMPyP to cells. After this period, plates were 
illuminated for 30 min [42]. Growth of C. albicans cells was not detected in the area, 
treated with 4.5 nmol of TMPyP. Therefore, photoaction of TMPyP led to cell death on 
the agar surface. These results indicate that photodynamic inactivation of cells, growing 
in vivo as localized foci of infection, on skin or on an accessible area to be irradiated, 
might also be possible [42]. Furthermore, a later study, made by the same group, 
showed that the photokilling of C. albicans cells by TMPyP seems to be mainly 
mediated by singlet oxygen [43]. 
 
Fig. 6: Chemical structure of TMPyP 
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1.2.4.4 XF-73 
XF-73 also belongs to the porphyrin-based class of photosensitizers, containing two 
positive charges, being oppositely connected via a propyl chain to the ring system (Fig. 
7) [44]. It has a MW of 694.81 g mol-1 and a singlet oxygen quantum yield of Φ∆ = 0.57 
(singlet oxygen production quantum yield of XF-73 was measured in our laboratory, 
according to the reference [40].) This PS was originally developed during a European 
Union project, entitled “Dynamicro”, for the development of a photodynamic treatment 
to eradicate and control the current spread of infectious antibiotic resistant 
microorganisms in humans (Destiny Pharma, UK). 
 
Fig. 7: Chemical structure of XF-73 
So, the charges have a high mobility to interact with cell walls of 
microorganisms [44]. So far XF-73 has shown a very high efficacy (reduction of >5 
log10) to kill bacteria of all known photosensitizers [45]. 
1.2.4.5 Phthalocyanines 
Phthalocyanines consist of four pyrrolic rings, connected via nitrogen bonds (Fig. 8). 
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Fig. 8: Chemical structure of a phthalocyanine 
These PSs have higher absorption in the far-red region of the spectrum (650-700 
nm) and consequently optimal tissue penetration by light [46] . The addition of central 
metal ions, like Zn2+ (zinc phthalocyanine) or Al3+ (aluminium phthalocyanine), 
produce long triplet states and enhance their singlet oxygen production [47]. A recent 
study showed successful photoinactivation of C. albicans biofilms, using two different 
phthalocyanines PSs. There, biofilms were incubated for 1.5 h with 6 µM of a gallium 
phthalocyanine (GaPc) and a zinc phthalocyanine (ZnPc). Then they were irradiated 
with red light (635 nm). An applied dose of 50 J cm-2 caused ~5 log10 decrease of cell 
survival. The authors suggest that the susceptibility of C. albicans biofilms to aPDT 
with these two PSs are a potential value for treatment of denture associated infections in 
the future [48]. 
1.2.5 Reactive oxygen species: Singlet oxygen 
Singlet oxygen is believed to be the main factor responsible for photodynamic action 
[49, 50]. This highly reactive oxygen species has a lifetime in biological systems as 
short as 10-6 s, and, consequently, limited diffusivity (<0.02 µm), which may enhance 
localized response, without damaging host tissues [51]. 
Multiple cellular targets are available for the photo-oxidative effect caused by 
singlet oxygen, including inactivation of enzymes and other proteins and peroxidation 
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of lipids, leading to the lyses of cell membranes, lysosomes, and mitochondria [25]. 
Thus, singlet oxygen, generated by the excitation of PSs, is a non-specific oxidizing 
agent, and there is so far no cellular defense against it [21]. Antioxidant enzymes, such 
as peroxide dismutase, catalase, and peroxidase, protect microbial cells against some 
oxygen radicals, but not against singlet oxygen, which even inactivates some 
antioxidant enzymes, for instance catalase and superoxide dismutase [52]. 
1.2.6 Mechanisms of resistance to aPDT 
So far the potential mechanisms of resistance to aPDT are the general mechanisms of 
drug resistance and may be associated to active efflux, altered drug uptake or altered 
intracellular trafficking of the photosensitizer [53]. It was reported that 
phenothiaziniumbased PSs, such as MB, are substrates of multidrug resistance (MDR) 
pumps in both Gram-positive and in Gram-negative bacteria [54]. The authors proposed 
that specific MDR inhibitors could be used in combination with phenothiazinium salts 
to enhance their photokilling efficacy [54]. The ability to photoinactivate biofilm 
bacteria was also significantly enhanced when using an inhibitor of efflux pump (EPI) 
with MB [55]. 
ATP-binding cassette (ABC) transporters and major facilitator super family 
(MFS) in C. albicans can affect the killing effect of aPDT using MB and red light. C. 
albicans strains overexpressing MFS system showed a slightly protective effect of MB-
aPDT phototoxicity, showing 1.5 log10 less reduction than parental cells. The effect of 
ABC overexpression was more prominent when compared with MFS overexpression in 
protecting against MB-mediated aPDT. Mutants overexpressing ABC transporters were 
resistant to aPDT killing, whereas the parental cells showed 5 log10 of killing under the 
same experimental conditions. The phototoxic effect of MB could be potentiated by the 
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ABC inhibitor verapamil, but not by the MFS inhibitor INF271. The authors suggested 
that the inhibition of fungal cell death, caused by the combination of aPDT-MB with 
MFS inhibitor may be explained by the hypothesis that the MFS channel can also serve 
as an uptake mechanism for MB [18]. 
However, PSs with molecular weights above 600-700 Da does not serve as 
substrate to efflux pumps, since porins exclude compounds above this molecular mass. 
Repetitive treatments of Staphylococcus aureus with a phthalocyanine derivative, which 
have a molar weight >1.300 Da did not induce the development of resistance. The 
authors supposed that larger PS molecules could not be internalized by the bacteria cells 
and that the PS molecules should accumulate in the superficial portions of the bacterial 
structures. Like that, the photodynamic action would promote oxidative damage at the 
exterior of the cell, causing cell wall or membrane disruption and consequent bacteria 
lyses [56]. 
Overall, the potential mechanisms of microorganisms to achieve resistance 
against aPDT, described above, are related to the PSs. In addition, antioxidant enzymes 
like superoxide dismutases and peroxidases protect cells against hydroxyl radicals, 
superoxide anions and hydrogen peroxide, which are ROS formed by the type I 
mechanism of action of aPDT. However, to date, no cellular defense against singlet 
oxygen is known (type II mechanism), which is proposed to be the predominant ROS 
formed during aPDT [21]. 
Heat shock proteins (Hsps) are a class of functionally related proteins, involved 
in the folding and unfolding of cellular proteins. These proteins are over expressed upon 
oxidative stress from the environment enabling microorganisms to survive such “stress 
situations” [57]. Therefore, the expression of Hsp might be increased upon the oxidative 
damage, caused by aPDT, preventing aggregation and refolding proteins, and thus can 
1 Introduction 17 
 
be a mechanism, whereby microbial cells could become resistant to aPDT [58, 59]. The 
Hsps DnaK and GroEL were upregulated in Escherichia coli and Enterococcus faecalis 
after aPDT-mediated by TBO. Consequently, E. coli survival was improved by 2 log10 
and E. faecalis by 4 log10. Combination of aPDT with an inhibitor of the HSP DnaK did 
not significantly potentiate the effect of aPDT in both microorganisms [60]. 
For C. albicans so far, it is not known, whether HSPs are upregulated after 
photodynamic treatment and also whether the overexpression of HSPs can protect C. 
albicans cells from the oxidative damage, caused during aPDT. But induction of heat 
shock response may not be enough to avoid cell death, since aPDT is a multihit process 
and many cellular sites can be damaged by the ROS, generated during the treatment 
[61]. 
1.2.7 Microbial biofilms 
Biofilms are structured microbial communities, characterized by sessile cells that are 
attached to natural (living tissues, natural aquatic systems) or abiotic moist surfaces 
(indwelling medical devices, industrial or potable water system piping) and embedded 
in a extracellular polymeric substance (EPS), such as glycoproteins and 
polysaccharides, produced by these cells itself (Fig. 9). The EPS, one of the 
distinguishing characteristics of biofilms, is made of polymeric substances, comprising 
polysaccharides, proteins, glycopeptides, lipids, lipopolysacharides and other materials 
that serve as a scaffold, holding the biofilm together [62, 63]. 
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Fig. 9. Biofilm formation: 1. Biofilm formation starts with the adherence of planktonic 
cells (free floating cells) to a biotic or abiotic surface; 2. The attached cells start to 
multiply, form microcolonies and produce the EPS. 3. Microbial cells produce a large 
amount of EPS and the microbial groups increase in size and thickness; 4. In the final 
stage of biofilm formation, cells may detach and form new biofilms or dispersing 
infections. 
Cells in a biofilm state show a distinct phenotype from those of their free-living 
planktonic counterparts by production of the EPS, reduced growth rates, and the up- and 
down-regulation of specific genes [63]. They constitute a unique niche for microbial 
growth, where these cells, attached to a surface and encased in the EPS, are protected 
from the action of antimicrobial agents and host cells [64]. Furthermore, biofilm is an 
organized community of cells, which are highly interactive and release molecule 
compounds termed autoinducers to communicate between them in a process called 
quorum sensing. This phenomenon regulates the number of microbial population and 
controls competition for nutrients. It has important implications in the infectious 
process, particularly for dissemination and for the establishment of distal sites of 
infection [65, 66]. C. albicans biofilms produce farnesol as a quorum sensing molecule, 
which blocks the yeast-to-hyphal conversion, required for biofilm formation [67]. 
The National Institutes of Health [68] states that 80% of all human microbial 
infections are caused by microorganisms (bacteria or fungi), growing in a biofilm state, 
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representing a serious problem in health care [68]. Of particular concern is the increased 
resistance of biofilms to antimicrobial agents compared to their planktonic counterparts. 
Microbial cells growing in a biofilm can tolerate antimicrobial agents at concentrations 
10–1000-times higher than needed to kill genetically equivalent planktonic microbial 
cells, and are also resistant to phagocytosis, making biofilms extremely difficult to 
eradicate from living hosts [69, 70]. In addition, biofilms can also act as reservoirs for 
persistent sources of infection in a host [71, 72]. 
There are multiple mechanisms, which account for biofilm increased resistance, 
when compared to their planktonic counterparts. These mechanisms vary with the 
microorganisms present in the biofilm, and the drug being applied. One mechanism of 
biofilm resistance to antimicrobial agents is the failure of an agent to penetrate the full 
depth of the biofilm due to the presence of the EPS. This structure can act as a physical 
barrier, thereby inhibiting drug diffusion to the cells within the biofilm and reducing the 
concentration of the drug, reaching the cells in the biofilm. Another hypothesis is that 
the EPS may slow the diffusion of the drugs within the biofilm, permitting enough time 
for microbial cells to upregulate drug resistance genes [73]. Another contributing factor 
might be that the cells within the biofilm have very slow growth rates as a consequence 
of nutrient deprivation, particularly at the base of the biofilm [74]. Biofilms may also 
harbor persister cells, which are cells that account for 0.1-1 % of the biofilm population 
and exhibit multidrug tolerance [75]. Upregulation of genes, coding for efflux pumps 
proteins, may also be a mechanism, whereby biofilms can resist the action of 
antimicrobial agents [76]. 
Another mechanism that may account for biofilm resistance might be the role of 
cross-resistance. Mild forms of stress prepare cells for subsequent stress conditions of a 
different nature. So, biofilm-grown cells live in a nutrient-poor, hypoxic environment 
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and these suboptimal growth conditions may result in increased tolerance to various 
forms of stress [62]. The interaction of these facts may lead to a decreased susceptibility 
of the biofilms to antimicrobial agents. Therefore, antimicrobial drugs with just one 
single mechanism of action, as the ones used routinely, are unlikely to be effective 
against biofilms. 
Biofilms not only tend to be more resistant to antimicrobial agents, but also to 
withstand host immune defenses. Antibodies and leucocytes have limited penetration 
into the biofilm. Like that cells within the biofilm remain hidden from antibodies and 
complement factor recognition, and thus from subsequent phagocytosis. This may result 
in the oxidative burst of phagocytes, leading to inflammation and destruction of nearby 
tissues [77]. 
1.2.8 Antifungal drugs 
The important antifungal drugs, currently used in the treatment of fungal infections, can 
be divided into 3 different classes, as follows: (i) polyene macrolides that lead to an 
alteration of membrane functions (amphotericin B [AmB] and its lipid formulations); 
(ii) azole derivatives that inhibit the 14α lanosterol demethylase, a key enzyme in 
ergosterol biosynthesis (ketoconazole, fluconazole, itraconazole, and voriconazole); and 
(iii) 1,3-β-glucan synthase inhibitors (echinocandins) [78]. 
Of these three classes of antifungal agents, only AmB and the echinocandins 
have shown in vitro activity against C. albicans biofilms [79, 80]. But even when using 
these drugs, biofilm infections caused by C. albicans, are extremely difficult, if not 
impossible to eradicate [80, 81]. In Latin America, amphotericin B (AmB) continues to 
be the antifungal drug, most commonly used for the treatment of invasive fungal 
infections, followed by fluconazole. Echinocandins and other AmB formulations are 
rarely used, because of their higher cost [5]. 
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1.2.8.1  Polyenes 
The polyene antifungal agents owe their name to the presence of alternating conjugated 
double bonds that constitute a part of their macrolide ring structure. The polyene 
antibiotics are all products of Streptomyces species. These drugs bind strongly to 
ergosterol, forming pores through the membrane, leading to the disruption of the 
osmotic integrity of the membrane, with leakage of intracellular potassium and 
magnesium, and also the disruption of oxidative enzymes in target cells, causing cell 
death [82, 83]. AmB can also induce oxidative stress in fungi cells, due to formation of 
ROS like superoxide, hydroxyl radicals and hydrogen peroxide, disrupting cell 
membrane and leading to cell death through membrane lipid peroxidation [84]. 
AmB is considered the gold standard for the treatment of many invasive or life-
threatening fungal infections and has been the mainstay of antifungal therapy for over 
50 years (Fig. 10). This can be explained by the fact that, besides the wide spectrum of 
action of AmB, resistance to polyenes is rare, and this in part due to the severe host 
toxicity, limiting the long-term use of these class of drugs [8, 85]. Resistance to 
polyenes is related to mutation in fungal ergosterol biosynthetic pathway, leading to 
accumulation of other sterols in the fungal membrane, which have less binding affinity 
for AmB [83]. Concurrent or previous therapy with azoles might also lead to AmB 
resistance, by altering the sterol type or the content in the membrane [78, 86]. In 
addition, catalase activity is also involved in resistance to AmB, leading to decreased 
cell susceptibility towards oxidative damage, caused by AmB [87]. 
The use of this agent is limited by significant drug host toxicity, such as renal 
dysfunction, which is likely due to the structural similarities between ergosterol and 
cholesterol in the mammalian cell membrane [85, 88]. Consequently, lipid formulations 
of AmB have been developed and they greatly reduce nephrotoxicity of the parental 
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drug. But the acquisition cost of these compounds are considerably more expensive than 
conventional AmB, ranging from 10 to 20 fold higher in cost per dose [89]. 
 
Fig. 10. Chemical structure of Amphotericin B 
1.2.8.2 Azoles 
The azole antifungal agents are the most widely used class of antifungals in the clinic 
[90]. They have a ring made of five atoms containing either two or three nitrogen 
molecules (the imidazoles and the triazoles respectively) [91]. They act by inhibiting the 
ergosterol biosynthetic enzyme 14α lanosterol demethylase, causing a block in the 
production of ergosterol and the accumulation of toxic sterols, culminating in a severe 
fungal membrane stress and inhibition of fungal growth [90, 92-94]. The fungistatic 
nature of azoles drugs contributes to the development of resistance in clinical isolates 
from immunocompromised hosts [95]. Approximately 81 % of patients with AIDS are 
estimated to be colonized with azole-resistant strains [96]. 
Another potential limitation of the azole antifungal drugs is the frequency of 
their interactions with drugs that are used in chemotherapy or in AIDS treatment, 
because they are metabolized via similar pathways in the liver, resulting in a decrease of 
azole concentration, or even in toxicity of the coadministered drug [97]. Fluconazole 
OH
OH
O H
OH
NH2
OH
O
O
O
OH
OOH O
H
OH
H
OH OH OH
OH
1 Introduction 23 
 
(Fig. 11), the most suitable azole for the treatment of superficial candidiasis and 
disseminated candidiasis, is used for prevention of candidiasis in intensive care units 
(ICU). The extensive use of fluconazole as prophylaxis in ICU patients became the 
leading cause of colonization of Candida-non-albicans species and increasing resistance 
to antifungal drugs [68, 98, 99]. 
 
Fig. 11: Chemical structure of fluconazole 
Resistance to azoles can occur by mutations that modify the target molecule or by 
the upregulation of multidrug efflux pumps coded for by multidrug resistance (MDR) or 
Candida drug resistance (CDR) genes [100, 101]. Besides, long-term use can cause life-
threatening liver toxicity [102]. 
1.2.8.3 Echinocandins 
The echinocandins are semisynthetic lipopeptides produced via chemical modification 
of natural products of fungi [101]. This class of drug inhibits the synthesis of 1,3-ß-D-
glucan, an essential component of the fungal cell wall, comprising 30%–60% of the 
fungal cell wall in Candida sp [101]. This leads to depletion of glucan polymers in the 
fungal cell, resulting in cell rupture and death. This is the first class of antifungal agents 
that target the fungal cell wall, the ideal target for the therapeutic treatment of fungal 
pathogens of humans, since mammalian cells do not have cell walls [92, 94, 103, 104]. 
Echinocandins are highly effective against Candida spp, including azole-
resistant strains, and also against Candida growing biofilm cells [105]. However, their 
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high price may limit their use as initial therapy for patients with fungemia (fungal 
infections in the bloodstream) [106] and clinical resistance attributed to point mutation 
in glucan synthase (FKS) genes coding for β-1,3-glucan-synthase has been reported in 
some Candida spp. [107]. 
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2 Photodynamic inactivation of Candida 
albicans biofilms 
2.1 Introduction 
C. albicans is a commensal organism in healthy individuals, colonizing several niches 
of the human body in the skin and mucosal surfaces, such as the oral cavity, the 
gastrointestinal tract, and the genitourinary tract of 30–70% of healthy individuals at 
any given moment [92, 108]. Both the normal bacterial flora of mucosal surfaces and 
epithelial layers act as physical barriers, as well as a functional immune system, 
maintaining the commensal phase of C. albicans colonization [109]. However, an 
imbalance between the host immunity and this opportunistic fungus may trigger 
infections of the skin, nails, and mucosal epithelia. In severely immunocompromised 
patients, the fungus can penetrate through epithelial layers into deeper tissues, reach the 
bloodstream, and disseminate within the body, infecting internal organs (invasive 
candidiasis), like heart, brain, kidney, and liver (Fig. 12) [5-7]. 
C. albicans is the major fungal pathogen of humans. It is the predominant fungal 
species, found on oral mucosal layers, in vaginal infections, and in invasive bloodstream 
infections [62]. This microorganism is responsible for 90%–100% of mucosal infections 
and for 50%–70% of episodes of candidemia (bloodstream infection caused by Candida 
spp) [110-113].  
In the United States, Candida spp. are the fourth most common cause overall of 
bloodstream infections, and they rank fourth to seventh in Europe [114-116]. In 
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multicenter studies, conducted in Brazil and in Mexico, it has been found that 4% of 
nosocomial bloodstream infections are caused by Candida spp [117]. 
 
Fig. 12: The steps of tissue invasion by Candida albicans: (1) adhesion to the epithelium; 
[118] epithelial penetration and invasion by hyphae; [119] vascular dissemination, which 
involves hyphal penetration of blood vessels and seeding of yeast cells into the 
bloodstream; and, (4) finally, endothelial colonization and penetration during 
disseminated disease. Adopted and modified from reference [108]. 
In immunocompromised patients, vaginal, esophageal, oropharyngeal, and urinary 
tract candidiasis are very frequent. In HIV patients, oropharyngeal candidiasis is a 
major cause of morbidity. Oral candidiasis may also lead to esophageal candidiasis, an 
even more distressing complication [120]. Oropharyngeal candidiasis affects 15-60 % 
of patients with haematologic or oncologic malignancies during the period of 
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immunosuppression [121], 7-48 % of patients infected with HIV, and over 90 % of 
those in advanced stage of the disease. In severely immunocompromised patients, 
relapse rates are high (30-50 %), usually occurring within 14 days of treatment 
cessation [122, 123]. 
Bloodstream infections by C. albicans are difficult to diagnose because of its 
nonspecific signs and symptoms, delaying appropriate treatment and resulting in 
substantial morbidity and mortality. The mortality rate, related to invasive candidiasis, 
can be up to 61%. Usually, an excess length of hospital stay of 30 days ist required, 
making the treatment more expensive [6, 8, 9]. 
The fact that C. albicans is the most common human fungal pathogen can be 
explained by its ability to survive in different environments in the host organism [52]. 
C. albicans has developed specialized virulence factors to rapidly adapt itself to local 
growth conditions, cause diseases, and overwhelm the host defense systems [9]. The 
ability to switch between unicellular yeast growth forms and a filamentous form is an 
important virulence trait (Fig. 13). Yeast cells are suited for dissemination in the 
bloodstream to target organs, whereas hyphae are invasive and allow C. albicans to 
firmly anchor and penetrate host epithelial and endothelial cells, damaging them 
through the release of hydrolytic enzymes and initiating candidiasis. Furthermore, 
hyphae cells can escape from phagocyte cells after host internalization [124]. 
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Fig. 13. C. albicans has ability to grow as unicellular budding yeast or in filamentous 
hyphal forms. 
Mutants that are unable to undergo morphogenesis are often attenuated in 
virulence [9, 10, 11]. Other virulence factors of C. albicans include secretion of 
hydrolytic enzymes such as proteinases, phospholipases enzymes, which enhance 
adhesion and facilitate invasion by destroying host cells [125], and adhesion to host 
cells and tissues by expression of cell surface glycoproteins, called adhesins [126]. But 
the major virulence factor in C. albicans pathogenensis is the formation of biofilms in 
host tissue surfaces (Fig. 14) [127]. 
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Fig. 14. Superficial infections
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Considering the substantial excess mortality due to candidemia and the 
difficulties encountered in administering early and effective antifungal therapy, 
prevention of epithelial 
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denture surfaces [62], as well as on human epithelial surfaces, such as the 
gastrointestinal, the bronchial [129], the genital tract and the skin [131]. 
Most cases of candidiasis at both mucosal and systemic sites are caused by 
biofilm-grown C. albicans cells [132]. In addition, this phenotype is less susceptible to 
antifungal agents, compared to its planktonic counterparts, and it can be up to 2000 
times more resistant to the effects of antimicrobial agents [66, 133]. 
The morphological heterogeneity is a unique feature of C. albicans biofilms and 
results in complex three-dimensional biofilm architecture [134]. They exhibit a highly 
heterogeneous architecture, composed of yeast and hyphae cells, and the fungal-derived 
EPS, which is comprised of polysaccharides, mainly ß-1,3 glucans, and proteins. 
Basically, biofilm formation proceeds over a period of 24–48 h, where adherent yeast 
cells are transformed to well-defined cellular communities, encased in the EPS [135]. C. 
albicans biofilm formation starts with: 1. Attachment of yeast cells to a biotic or abiotic 
surface. 2. Initial attachment is followed by hyphae formation and production of EPS. 3. 
The biofilm becomes a thick layer of EPS enveloping an intricate network of yeasts and 
hyphaes. 4. Cells are released from the biofilm, spreading into the environment and 
forming new biofilms or dispersing infections (Fig. 15) [136]. 
 
Fig. 15. Biofilm development of Candida albicans: 1. Candida albicans biofilm formation 
starts with the adherence of planktonic cells to a surface. 2. Initial attachment is followed 
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by hyphae formation and production of EPS. 3. The biofilm becomes a thick layer of EPS 
enveloping an intricate network of yeasts and hyphaes. 4. Cells are released from the 
biofilm, spreading into the environment and forming new biofilms or dispersing infections 
There are multiple hypotheses to explain, why C. albicans biofilms are much 
more resistant to antifungal drugs than planktonic cultures. In addition to the factors, 
already mentioned for microbial biofilms, such as presence of EPS, slow growth rate, 
overexpression of drug efflux pumps, and presence of persister cells, C. albicans 
biofilms have been reported to show decreased content of ergosterol and diminished 
levels of ergosterol biosynthetic gene expression [76, 137]. These changes in membrane 
sterol composition during biofilm formation might explain resistance to drugs such as 
AmB and the azoles, which target sterols and sterol biosynthesis [138]. The elevated 
levels of ß-1,3 glucan levels in the cell wall and biofilm EPS of C. albicans, in response 
to environmental signals, may physically interact with antifungal drugs and inhibit the 
penetration to the site of action [139]. 
Thus, a clear need exists for an effective nonantibiotic treatment, mainly against 
cells, growing as a biofilm. Biofilms are the leading cause of microbial infections in 
humans and represent a serious problem in health care [140]. Therefore, in this study 
the photodynamic action of a new porphyrine derivative XF-73 against C. albicans 
planktonic and biofilm cells was investigated and the results were compared with the 
photodynamic action of the standard PS TMPyP, regarding uptake, phototoxicity and 
mechanism of action. 
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2.2 Material and Methods 
2.2.1 Strains of C. albicans 
One to three colonies of C. albicans (ATCC-MYA-273, LGC Standards GmbH, 
Germany) were picked up from agar plates with a sterile inoculating loop, transferred to 
culture tubes containing 5 mL of Sabouraud Dextrose Broth (SDB) (Sigma Chemical 
Co., St. Louis, Mo), and cultured overnight. When the cultures reached the stationary 
phase of growth, the cells were harvested by centrifugation (200 g, 5 min) and washed 
once with Dulbecco's phosphate-buffered saline (PBS without Ca2+ and Mg2+; PAA 
Laboratories GmbH, Austria). For experiments with planktonic cells, approximately 
5×107 cells mL-1 were prepared in PBS. 
2.2.2 Formation of C. albicans biofilm 
Different conditions were tested to find the optimal conditions to form C. albicans 
biofilms. Planktonic cells were diluted at different densities: 104 to 107 cell mL-1 and in 
different fetal bovine serum (FBS; PAN Biotech, Aidenbach, Germany) concentrations: 
25% to 100% FBS diluted in PBS. The incubation times of these suspensions were 
varied between 24 and 48 h. The best condition found to form the biofilms, used in this 
study, were: C. albicans planktonic cells diluted to 106 cells mL-1 in 25% of FBS and 
200 µL were added to sterile flat-bottomed 96-well polystyrene plates (Costar® 96 Well 
Clear Flat Bottom, TC-treated microplate, Corning Incorporated, Corning, New York, 
USA), incubated at 37 °C for 24 h without shaking. This set up was used for further 
experiments. 
The cell density of 106 cells mL-1 provided an optimal recovery rate of 105 cells 
mL-1. All tested concentrations of FBS induced robust biofilm formation (data not 
2 Photodynamic inactivation of Candida albicans biofilms 33 
 
showed). 25% of FBS was used, since porphyrins are known to bind serum proteins 
[141] and increasing FBS concentrations may reduce the attachment/uptake of the PSs 
by microbial cells, due to the nonspecific binding of PSs molecules to serum proteins. 
Biofilms incubated for 48 h became too fragile to permit manipulation. So 24 h biofilms 
were used in the study (Fig. 16). 
 
Fig. 16. Biofilm growing cells, used in this study: 1. Empty plate, the 2. Plate containing 
biofilm growing cells and 3. Plate containing biofilm growing cells stained by 5% of crystal 
violet. Crystal violet stains the biofilm EPS and the cells within the biofilm. 
2.2.3 Photosensitizers and light source 
The photosensitizer 5,10,15,20-Tetrakis(1-methyl-4-pyridyl)-21H,23H-porphine, tetra-
p-tosylate salt (TMPyP) was purchased from Sigma Aldrich (Taufkirchen, Germany), 
purity 97%. The dicationic 5,15-bis-[4-(3-Trimethylammoniopropyloxy)-phenyl]-
porphyrin (XF-73), was synthesized by Xiangdong Feng (Solvias Company, Basel, 
Switzerland) and kindly provided by Destiny Pharma Ltd. (Brighton, United Kingdom).  
Both photosensitizers were dissolved in bidistilled water at a concentration of 500 µM, 
passed through a 0.22 µm pore-size filter, and stored at 4°C until usage. The irradiation 
of the samples was performed using an incoherent light source (UV236) λem = 418 ± 20 
nm), provided by Waldmann GmbH (Schwenningen, Germany) (Fig. 17). The maximal 
fluence rate at the level of the irradiated samples was 13.4 mW cm-2. Planktonic cells 
were irradiated for 15 min (12.1 J cm-2) and biofilms for 60 min (48.2 J cm-2). 
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Fig. 17. Spectral emission of the light source with an emission peak at 418 nm (blue). 
2.2.4 Binding assay 
Planktonic and biofilm cells were incubated in the dark with increasing concentrations 
of the PSs for 60 and 120 min respectively. The cells were washed twice to remove 
unbound PSs molecules. The pellet was lysed with Sodium Dodecyl Sulfate (SDS) 2% 
overnight at 37°C. Cell lysates were centrifuged for 5 min at 37 °C and the spectra of 
TMPyP and XF-73 in the supernatant was measured by absorbance spectroscopy using 
a Beckman DU640 spectrophotometer (Beckman Instruments GmbH, Munich, 
Germany). 
2.2.5 Localization of XF-73 and TMPyP in C. albicans 
To determine the localization of TMPyP in C. albicans planktonic cells and the 
localization of XF-73 in C. albicans biofilms, C. albicans planktonic cells were 
incubated with 1 µM of TMPyP for 15 min and washed once with PBS. C. albicans 
biofilms were incubated with 100 µM of XF-73 for 1 h and washed once with PBS. 
Thereafter, the distribution of TMPyP and XF-73 was examined by fluorescence 
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microscopy (Zeiss Axiotech, Goettingen, Germany) using an appropriate dual band 
filter set (Omega Optical, Brattleboro, VT, USA) for excitation (405nm ± 40 nm) and 
emission (λem600nm longpass). Light microscopy images were done in parallel. 
Fluorescence images were superimposed onto the corresponding light microscopy 
image using an image processing program (Image-Pro Plus 5.0; Media Cybernetics, 
Silver Spring, MD, USA). 
2.2.6 Photodynamic inactivation of C. albicans planktonic cells 
Cells submitted to aPDT were incubated in the dark with different concentrations of the 
PSs (0 to 2µM) for 15 min under agitation. 200 µL of cell suspension were transferred 
to sterile flat-bottomed 96-well polystyrene and illuminated for 15 min (13.4 mW cm-2, 
12.1 J cm-2). Illumination was done from the bottom side of the 96-well plate to avoid 
refraction of the light in the cell culture media. Controls included: C. albicans cells kept 
in the dark and not treated with PS (normal control), C. albicans cells exposed just to 
the light (light control), and C. albicans cells treated just with the PS (dark control). 
Immediately after treatment, fungal viability was monitored by the colony forming unit 
assay (CFU assay). 
2.2.7 Photodynamic inactivation of C. albicans biofilm cells 
After 24 h of incubation, the biofilms were washed once to remove loosely attached 
cells. The cells were incubated with increasing concentrations of the PSs for 4 h in the 
dark at 37°C. Thereafter, cells were illuminated for 60 min (13.4 mW cm-2, 48.2 J cm-2). 
Then, the biofilms were detached from the bottom of the well by scraping the bottom of 
the microplate with a pipette tip. Afterwards, they were transferred to an Eppendorf tube 
containing 1 mL of PBS. The cells were then placed in an ultrasonic water-bath 
chamber with a frequency of 35 kHz (Qualilab USR30H, Merck Eurolab GmbH, 
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Bruchsal, Germany) and vigorously vortexed (REAX top, Heidolph Instruments GmbH 
& Co. KG, Schwabach, Germany) for 1 min each procedure. Thereafter, sensitivity of 
C. albicans biofilms to aPDT was determined by CFU assay. 
2.2.8 Photodynamic inactivation of C. albicans cells resuspended 
from biofilms 
Additional experiments were made to assess the susceptibility of C. albicans cells, 
which were resuspended from preformed biofilms. Twenty four hours old biofilms were 
washed twice, detached from the well microplate by scrapping, and transferred to an 
Eppendorf tube with 1 mL of PBS. The cells were then placed in an ultrasonic water-
bath chamber with a frequency of 35kHz (Qualilab USR30H, Merck Eurolab GmbH, 
Bruchsal, Germany) and vigorously vortexed (REAX top, Heidolph Instruments GmbH 
& Co. KG, Schwabach, Germany) for 1 min each procedure. This procedure was done 
for disrupting the biofilm structure and getting individual cells of C. albicans into the 
suspension. Thereafter, the sensitivity of C. albicans cells to aPDT was evaluated as 
stated above for the experimental set up for planktonic cells. 
2.2.9 Amphotericin B activity against C. albicans planktonic and 
biofilm cells 
Planktonic cells were incubated with 0; 0.1; 1; 5, 10, 50 and 100µg mL-1 of AmB, for 
30 min concerning the overall photodynamic treatment time (15 min incubation with PS 
+ 15 min illumination). Biofilms were incubated with 0; 0.1; 1, 10; 50 and 100 µg mL-1 
of AmB for 5 h (4 h incubation with PS + 1 h illumination). Besides, planktonic and 
biofilm cells were also incubated with AmB for 24 h, which is the standard time for the 
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susceptibility tests of C. albicans planktonic cells in vitro. Fungal viability was 
monitored by the CFU assay. 
2.2.10 Colony forming unit assay 
The colony forming unit assay (CFU assay) was used to estimate the viable number of 
microbial cells after phototoxic treatments. For this, ten-fold serial dilutions in SBD 
were made and aliquots of 0.1 mL were seeded onto Sabouraud Dextrose Agar (SDA) 
and cultured for 48 h at 37°C. Thereafter, the number of surviving colonies was counted 
(CFU mL-1). 
2.2.11 Multi-channel 3D fluorescent microscopy images 
Biofilms were formed, as described before (section 2.2.2), using cell culture dishes of 
the size of 35×10 mm2 (Cellstar, Frickenhausen, Germany). Biofilms were stained with 
a live/dead biofilm viability kit (Molecular Probes, Eugene, OR, USA). The kit contains 
two nucleic acid intercalators, membrane-permeable Syto-9 and membrane-
impermeable propidium iodide. Living cells are stained green and dead cells stained 
orange-red. The final concentrations of dyes were as follows: 0.01 mM for Syto-9, 0.06 
mM for propidium iodide. Additionally, 200 µg mL-1 of Concanavalin A (ConA)-Texas 
Red conjugate (Molecular Probes, Eugene, OR, USA) was used to stain the biofilm EPS 
in red. Fluorescence microscopy was performed using a Zeiss Observer Z1 inverted 
fluorescence microscope with ApoTome (Zeiss) and AxioVision software (v 4.6.2.0, 
Zeiss, Jena, Germany) using appropriate filter-sets for excitation and emission of Con A 
(λex590nm/λem615nm), SYTO 9 (λex485nm/λem500nm), and propidium iodide 
(λex535nm/λem617nm). 
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Light microscopy images were done in parallel. Fluorescence images were 
superimposed onto the corresponding light microscopy image using an image 
processing program AxioVision software. 
2.2.12 Singlet oxygen luminescence signal from biofilms, incubated 
with XF-73 
The biofilms were formed, as already described, for phototoxic experiments (section 
2.2.2) in cell culture dishes (35×10 mm2). The biofilms were incubated after formation 
with 100 µM of XF-73 for 1 h and previous to the detection of 1O2 luminescence the 
cells were either non-washed or washed with pure H2O once. After incubation, the 
biofilms were excited with a frequency doubled Nd:YAG-Laser (PhotonEnergy, 
Ottensoos, Germany) with a wavelength λ = 532 nm, power output P = 50 mW, 
repetition rate f = 2 kHz, and with a pulse energy of E = 2.5·10-5 J. Every sample was 
irradiated with 40.000 laser pulses, which equals an irradiation time of 20 s. The spot 
size of the excitation laser covered an area of 7 cm2 using an optical lens in regard to the 
size of the dishes. The 1O2 luminescence was directly detected by time resolved 
measurements at 1270 nm (LOT Oriel GmbH, Darmstadt, Germany, 30 nm FWHM 
filter) in near-backward direction with respect to the exciting beam. An infrared-
sensitive photomultiplier tube (PMT, R5509-42, Hamamatsu Photonics Deutschland 
GmbH, Herrsching, Germany) with an additional 950 nm cut-off-filter (Omega 
Opticals, Photomed GmbH, Seefeld, Germany) was used. The time resolved 
luminescence signals were fitted based on the Levenberg-Marquardt-algorithm, as 
described previously [143]. These experiments were done in collaboration with the 
Dipl.-Phys. Ariane Felgenträger, Department of Dermatology, University Hospital 
Regensburg. 
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2.2.13 Data analysis 
All results are shown as medians, including 25% and 75% quartiles, which were 
calculated from the values of at least 3 independent experiments. Each experiment was 
conducted in triplicates using Prism 4 for Windows (GraphPad Software Inc. San 
Diego, CA, USA). The calculation (reduction of CFU mL-1) was referred to the 
untreated, so called dark controls, which were neither incubated with TMPyP or XF-73 
nor illuminated. In Figs. 19-27, medians on or below the green or red horizontal line 
represent ≥99.9% or ≥99.999% efficacy of fungal killing, corresponding to at least three 
or five magnitudes of log10 reduction compared to the respective matching untreated 
controls (no light and no photosensitizer). A reduction of at least three magnitudes of 
log10 of viable median numbers of C. albicans was stated as biologically relevant with 
regard to the guidelines of hand hygiene [144, 145]. 
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2.3 Results 
The photodynamic efficacy of both XF-73 and TMPyP in combination with blue light 
against C. albicans planktonic and biofilm cells was investigated. 
2.3.1 Absorption and fluorescence spectra 
The absorption spectrum of TMPyP and XF-73 consists of a typical absorption 
spectrum of a porphyrin, showing a Soret band at 418 nm, and Q bands at 516, 551, 
592, and 648 nm in H20 [146]. The Figs. 18 and 19 show the concentration-dependent 
absorption of TMPyP and XF-73 respectively. 
 
Fig. 18: Absorption spectra of TMPyP in H2O in the range between 300 and 700 nm (Soret 
band and Q-bands I-IV) at different concentrations. 
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Fig. 19: Absorption spectra of XF-73 in H2O in the range between 300 and 700 nm (Soret 
band and Q-bands I-IV) at different concentrations. 
2.3.1 Fluorescence microscopy of TMPyP and XF73 in C. albicans 
Fluorescence microscopy was used to visualize TMPyP and XF73 uptake/binding by C. 
albicans cells. Fig 20 B shows a clear distribution of TMPyP around the cell wall and 
inside of C. albicans planktonic cells. For XF73, the same distribution was detected in 
planktonic cells (data not shown). 
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Fig. 20. Localization of TMPyP in C. albicans planktonic cells. C. albicans planktonic cells 
were incubated for 15 min with TMPyP. The distribution of TMPyP was examined by 
fluorescence microscopy. A) shows C. albicans biofilms incubated with TMPyP that were 
imaged by brightfield microscopy; B) shows C. albicans biofilms incubated with TMPyP 
that were imaged by fluorescence microscopy; C) shows the overlay of the brightfield 
image (A) and the fluorescence image (B). (×40 objective). 
Fig 21 B shows the distribution of XF73 in C. albicans biofilms. XF73 
fluorescence signals were detected in both yeast and hyphae of C. albicans. For 
TMPyP, fluorescence signals were also detected in both yeast and hyphae cells (data not 
shown). 
A
C
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Fig. 21. Localization of XF-73 in C. albicans biofilms. C. albicans biofilms were incubated 
for 15 min with XF-73. The distribution of XF-73 was examined by fluorescence 
microscopy. A) shows C. albicans biofilms incubated with XF73 that were imaged by 
brightfield microscopy; B) shows C. albicans biofilms incubated with XF73 that were 
imaged by fluorescence microscopy; C) shows the overlay of the brightfield image (A) and 
the fluorescence image (B). (×20 objective). 
2.3.2 Binding experiments 
The efficacy of aPDT depends on the amount of PS, attached or uptaken by the cells, 
because singlet oxygen, generated by aPDT, has a short diffusion rate and the 
localization of the PS in the cell is supposed to be the first target of aPDT. Therefore, 
the binding of both PSs to the cells was determined. XF-73 attached better to both cell 
phenotypes than TMPyP. XF-73 attached better to planktonic cells than biofilm. On the 
other hand, attachment of TMPyP to both cell phenotypes was almost the same (Fig. 22 
and 23). 
A B
C
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Fig. 22. Binding of XF-73 (dashed) and TMPyP (solid line) in C. albicans planktonic cells. 
C. albicans planktonic cells were incubated for 60 min with each PS. The relative 
absorption of the PSs in the supernatant was measured by absorbance spectroscopy. 
 
Fig. 23. Binding of XF-73 (dashed) and TMPyP (solid line) in C. albicans biofilm cells. C. 
albicans biofilms were incubated for 120 min with each PS. The relative absorption of the 
PSs in the supernatant was measured by absorbance spectroscopy. 
2.3.3 Photodynamic inactivation of C. albicans planktonic cells 
Incubation of planktonic cells for 15 min with 2 µM of TMPyP, followed by irradiation 
with blue light (12.1 J cm-2), caused a 6 log10 cell inactivation (Fig. 24), whereas only 
0.5 µM of XF-73 was necessary to reach the same killing values (Fig. 25). No dark 
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toxicity towards C. albicans planktonic cells was detected with the highest PSs 
concentrations used. Furthermore, light alone did not show any significant toxicity 
toward C. albicans. 
 
Fig. 24. APDT treatment of C. albicans planktonic cells. C. albicans planktonic cells were 
incubated with different concentrations of TMPyP for 15 min. The samples were 
irradiated with 12.1 J cm-2. A CFU assay was performed immediately after aPDT, and 
surviving colonies were counted 24 h later. Black dashed line: baseline CFU/ml; green 
dashed line: reduction of 3 log10 steps in viable C. albicans (reduction 99.9%); red dashed 
line: reduction of 5 log10 steps in viable C. albicans (reduction 99.999%). (n = 3 
experiments; median ± interquartile range). The arrow marks the lower detection limit of 
the CFU assay. 
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Fig. 25. APDT treatment of C. albicans planktonic cells. C. albicans planktonic cells were 
incubated with different concentrations of XF-73 for 15 min. The samples were irradiated 
with 12.1 J cm-2. A CFU assay was performed immediately after aPDT, and surviving 
colonies were counted 24 h later. Black dashed line: baseline CFU/ml; green dashed line: 
reduction of 3 log10 steps in viable C. albicans (reduction 99.9%); red dashed line: 
reduction of 5 log10 steps in viable C. albicans (reduction 99.999%). (n = 3 experiments; 
median ± interquartile range). The arrows mark the lower detection limit of the CFU 
assay. 
2.3.4 Photodynamic inactivation of C. albicans biofilm cells 
For both PSs, higher PSs concentrations and light doses, as well as longer incubation 
times with the PSs were necessary to kill biofilm cells compared to planktonic cells. 
Incubation of the biofilms for 4 h with different concentrations of the PSs, followed by 
illumination with a light dose of 48.2 J cm-2, caused a decrease in viability. TMPyP at a 
concentration of 50 µM exhibited a photodynamic killing efficacy of 5 log10 (Fig. 26). 
At this concentration, a dark toxicity was observed (2.3 log10). In contrast, only 1 µM of 
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XF-73 caused the same photokilling rate as TMPyP, without causing dark toxicity in the 
cells (Fig. 27). Light alone, did not have an effect on cell viability. 
 
Fig. 26. APDT treatment of C. albicans biofilm cells. C. albicans biofilm cells were grown 
on the surface of 96 well plates for 24h. After incubation with different concentrations of 
TMPyP for 4 h, the samples were irradiated with 48.2 J cm-2. A CFU assay was performed 
immediately after aPDT, and surviving colonies were counted 24 h later. Black dashed 
line: baseline CFU/ml; green dashed line: reduction of 3 log10 steps in viable C. albicans 
(reduction 99.9%); red dashed line: reduction of 5 log10 steps in viable C. albicans 
(reduction 99.999%). (n = 3 experiments; median ± interquartile range). The arrow marks 
the lower detection limit of the CFU assay. 
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Fig. 27. APDT treatment of C. albicans biofilm cells. C. albicans biofilm cells were grown 
on the surface of 96 well plates for 24h. After incubation with different concentrations of 
XF-73 for 4 h, the samples were irradiated with 48.2 J cm-2. A CFU assay was performed 
immediately after aPDT, and surviving colonies were counted 24 h later. Black dashed 
line: baseline CFU/ml; green dashed line: reduction of 3 log10 steps in viable C. albicans 
(reduction 99.9%); red dashed line: reduction of 5 log10 steps in viable C. albicans 
(reduction 99.999%). (n = 3 experiments; median ± interquartile range). The arrows mark 
the lower detection limit of the CFU assay. 
To determine whether the biofilm EPS is responsible for the increased resistance 
of biofilms, retarding the diffusion or excluding the PS within the cells, experiments 
were done with cells disrupted from the biofilm. These cells were then detached by 
scraping the microplate wells, resuspended in PBS, followed by sonication and 
vortexing to create a suspension of planktonic cells. Thus, these cells presumably have 
lost most of their EPS, since the EPS is responsible for keeping the organized structure 
of the biofilm. The results showed that resuspended biofilm cells were more susceptible 
to aPDT with XF-73 than intact biofilm populations (Fig. 28), suggesting that the EPS 
might play a role in aPDT resistance. 
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Fig. 28. APDT treatment of C. albicans cells resuspended from biofilms. C. albicans cells 
were disrupted from the biofilms with the tip of a pipette. The cells were then transferred 
to an Eppendorf tube with 1 mL of PBS, sonicated and vortexed for 1 min each, incubated 
with different concentrations of XF-73 for 15 min and irradiated with 12.1 J cm-2. A CFU 
assay was performed immediately after aPDT, and surviving colonies were counted 24 h 
later. Black dashed line: baseline CFU/ml; red dashed line: reduction of 3 log10 steps in 
viable C. albicans (reduction 99.9%); green dashed line: reduction of 5 log10 steps in viable 
C. albicans (reduction 99.999%). (n = 3 experiments; median ± interquartile range). The 
arrows mark the lower detection limit of the CFU assay. 
2.3.5 Amphotericin B activity against C. albicans planktonic and 
biofilm cells 
To compare the action of AmB with aPDT, C. albicans planktonic and biofilm cells 
were treated with AmB for the same time period as aPDT. Planktonic cells, incubated 
for 30 min with AmB, were not killed with a concentration as high as 100 µg mL-1 of 
AmB (Fig. 29 A). Planktonic cells were killed with AmB only after a treatment time of 
24 h with 2.5 µg mL-1 of the drug (Fig. 29 B). 
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Fig. 29. AmB treatment of C. albicans planktonic cells. C. albicans planktonic cells were 
incubated with different concentrations of AmB for (A) 15 min and (B) 24 h. A CFU assay 
was performed immediately after aPDT, and surviving colonies were counted 24 h later. 
Black dashed line: baseline CFU/ml; green dashed line: reduction of 3 log10 steps in viable 
C. albicans (reduction 99.9%); red dashed line: reduction of 5 log10 steps in viable C. 
albicans (reduction 99.999%). (n = 3 experiments; median ± interquartile range). 
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Biofilms, treated with AmB for the same time period as aPDT (5 h), were killed 
with 50 µg mL-1 (Fig. 30) and biofilms, incubated with AmB for 24 h, were killed with 
10 µg mL-1(Fig. 31). 
 
Fig. 30. AmB treatment of C. albicans biofilm cells. C. albicans biofilm cells were grown on 
the surface of 96 well plates for 24h. C. albicans biofilm cells were incubated with different 
concentrations of AmB for 5 h. A CFU assay was performed immediately after aPDT, and 
surviving colonies were counted 24 h later. Black dashed line: baseline CFU/ml; green 
dashed line: reduction of 3 log10 steps in viable C. albicans (reduction 99.9%); red dashed 
line: reduction of 5 log10 steps in viable C. albicans (reduction 99.999%). (n = 3 
experiments; median ± interquartile range). The arrows mark the lower detection limit of 
the CFU assay. 
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Fig. 31. AmB treatment of C. albicans biofilms. C. albicans biofilms were grown on the 
surface of 96 well plates for 24h. C. albicans biofilm cells were incubated with different 
concentrations of AmB for 24 h. A CFU assay was performed immediately after aPDT, 
and surviving colonies were counted 24 h later. Black dashed line: baseline CFU/ml; green 
dashed line: reduction of 3 log10 steps in viable C. albicans (reduction 99.9%); red dashed 
line: reduction of 5 log10 steps in viable C. albicans (reduction 99.999%). (n = 3 
experiments; median ± interquartile range). The arrows mark the lower detection limit of 
the CFU assay. 
2.3.6 Multi-channel 3D fluorescent microscopy images 
Fluorescence images confirmed that biofilms, used in this study, were composed of a 
mixture of yeasts, and hyphae. The live/dead staining kit was used to distinguish 
between living (green stained), and dead C. albicans cells (red stained) within the 
biofilm. 24 h old biofilms were stained and the fluorescence intensities of the live/dead 
staining were evaluated. The evaluation of 3 independent biofilms showed that 95 +/- 
5% of living C. albicans cells can be detected within the biofilms. Fig. 32 shows 
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exemplarily the fluorescence distribution of a live/dead staining of a biofilm with living 
(green-stained) and dead (red-stained) C. albicans cells. 
 
Fig. 32. Fluorescence image of C. albicans biofilm labeled with live/dead staining: 
Fluorescence image of a 24 h old biofilm composed of yeasts and hyphae cells. Biofilms 
were stained with live/dead biofilm viability kit, where Syto 9 labeled live cells in green 
and Propydium iodide labeled dead C. albicans cells in red (×40 objective). 
In addition, the presence of the EPS, a defining characteristic of biofilms, was 
confirmed by staining it with ConA-Texas Red conjugate. (Fig. 33). 
hyphae
yeast
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Fig. 33. Fluorescence image of C. albicans EPS labeled with Concanavalin A (ConA)-
Texas Red conjugate. Fluorescence image of a 24 h old biofilm stained with Syto 9 (fungi 
cells stain in green) and ConA labeled EPS in red (×40 objective). 
2.3.7 Singlet oxygen luminescence signal from C. albicans biofilm 
cells incubated with TMPyP and XF-73  
The spectrally resolved 1O2 luminescence signal observed in C. albicans biofilm cells, 
incubated with TMPyP and XF-73, was detected  at 1270 nm, which is characteristic for 
1O2 luminescence. 
 
matrix
2 Photodynamic inactivation of Candida albicans biofilms 55 
 
This indicates that TMPyP and XF-73 act as photosensitizers against C. albicans 
biofilm via the intermediacy of 1O2. The decay time of the 1O2 luminescence of the 
washed incubated biofilms is in the range of µs with tTMPyP,1 = (4.88 ± 0.5) µs, tTMPyP,2 = 
(2.09 ± 0.2) µs and tXF-73,2 = (6.61 ± 0.7) µs. The 1O2 luminescence signal showed a 
smaller intensity, when the biofilm was incubated with TMPyP and subsequently 
washed (Fig. 34), compared to the XF-73 (Fig. 35). No rise time of 1O2 could be fitted 
for XF-73 activated by light in C. albicans biofilms. Singlet oxygen is the most 
important ROS formed during aPDT. Therefore it was investigated, whether 1O2 could 
be responsible for the XF/TMPyP photodynamic killing in C. albicans biofilms. 
 
 Fig. 34. Time resolved singlet oxygen luminescence: Biofilms of C. albicans, incubated 
with 100 µM of TMPyP. The biofilm was washed with H2O and immediately irradiated 
with the Nd:YAG laser at 532 nm. The data show a decay time [61] of the 1O2 
luminescence signal in the typical range of µs 
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Fig. 35. Time resolved singlet oxygen luminescence: Biofilms of C. albicans, incubated with 
100 µM of XF-73. The biofilm was washed with H2O and immediately irradiated with the 
Nd:YAG laser at 532 nm. The data show a decay time [61] of the 1O2 luminescence signal 
in the typical range of µs 
2.4 Discussion 
Most manifestations of candidiasis are associated with the formation of Candida 
biofilms [147]. In addition, biofilms are less susceptible to antifungal agents, compared 
to its planktonic counterparts [132]. The antimicrobial drugs in current use, like AmB, 
have the ability to kill planktonic cells rather than biofilm cells. The problem is that 
over 80% of microbial infections in the human body are caused by cells growing in a 
biofilm state, which presents increased resistance to antimicrobial treatments, when 
compared to planktonic cells [140]. Biofilms present cells in different metabolic states, 
from rapidly proliferating to absolutely dormant. This fact frustrates efforts to control 
biofilms with antimicrobial agents. In addition, biofilms display some different 
characteristics than planktonic cells, like penetration and physiological heterogeneity. 
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So, it is not possible to predict the efficacy of an antimicrobial treatment against biofilm 
from data, collected using planktonic cells. In this way, growing microbial cells as part 
of a biofilm increases the relevance of test results [148].  
The facts, stated above, ensure the need for effective antimicrobial therapies that 
can prevent and destroy biofilm of C. albicans. In this investigation, it was 
demonstrated for the first time that both TMPyP and XF-73 combined with blue light 
could kill 99.999% of C. albicans growing as a biofilm, whereas XF-73 was more 
efficient and acted at lower concentrations than TMPyP. 
The binding of PSs by microorganisms is an important feature for the efficacy of 
aPDT. Demidova and Hamblin (2005) found that the efficacy of aPDT is dependent on 
the amount of PS binding [28]. It was already shown that TMPyP is an active PS against 
C. albicans planktonic cells [42]. Although having less positive charges, our results 
showed that XF-73 can bind better to both C. albicans phenotypes, when compared to 
TMPyP. Consequently, XF-73 demonstrated a greater photokilling efficacy, compared 
to TMPyP, regardless of planktonic or biofilm growing Candida. Using the same 
conditions as for TMPyP (incubation time and light dose), 0.5µM of XF-73 was 
necessary to kill >6 log10 of planktonic cells vs. 2 µM of TMPyP. 
For biofilms, 1 µM of XF-73 were necessary to destroy >5 log10 cells vs. 50 µM 
of TMPyP upon light activation. To our knowledge, it is the first time that aPDT caused 
such an extensive inactivation rate of C. albicans biofilms. Biofilms were killed with a 
concentration of XF-73 two times higher than the concentration, necessary to kill 
planktonic cells. On the other hand, the concentration of TMPyP, necessary to kill C. 
albicans biofilm cells, was 25 times higher than the concentration, used to kill 
planktonic cells. 
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The phototoxicity of both PSs is influenced by the position of positive charges. In 
XF-73, the cationic groups were separated from the tetrapyrrol ring system of the PS by 
an alkyl chain as a spacer. Thus, the charges have a high mobility and a minimal 
influence on the photophysical properties of the porphyrin. Therefore, the spacer 
provides a high mobility of the charges, which could facilitate the interaction with C. 
albicans cell wall. TMPyP in turn possesses four positive charges, located near the 
tetrapyrrol rings, conferring to the drug a planar, rigid structure, making the rotation 
restricted on the axis of the planar structure. 
Furthermore, the action of positively charged drug molecules can be retarded by 
the presence of negatively charged EPS [149]. Like that, TMPyP, which has more 
positive charges than XF-73, will form stronger electrostatic interaction with the EPS, 
retarding even more the diffusion of the PS within the biofilm. 
Planktonic cells were eliminated more rapidly and at lower concentrations of 
both PSs, when compared with biofilms. There is more than one reason for the 
increased resistance of Candida biofilms to antimicrobial treatments, when compared to 
planktonic cells. Presence of the EPS, inhibiting drug diffusion to the cells within the 
biofilm and reducing the concentration of the drug reaching the cells in the biofilm [73], 
up regulation of multidrug resistance genes; slow growth rate leading to slow and 
insufficient drug uptake as result of nutrient limitation. Therefore, antimicrobial drugs 
with just one single mechanism of action, like AmB, are unlikely to be effective against 
biofilms [122]. However, aPDT acts via multihit processes and is capable of inducing 
oxidative damage to the whole biofilm structure during the treatment. So, in addition to 
the inactivation of the microorganisms within the biofilm, aPDT also disrupts the 
biofilm structure [55]. The high chemical reactivity of singlet oxygen ensures that aPDT 
has also a direct effect on extracellular molecules, like the polysaccharides, present in 
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the EPS. Such a dual activity of aPDT can be an advantage, because it may avoid new 
colonization and prevent recurrence infection [150]. If one treatment is insufficient to 
disrupt biofilm structures and to inactivate its cells within, repeated aPDT treatments 
can be conducted, since this technique does not induce resistance so far. 
To investigate, whether the reduced susceptibility of biofilm could be related to 
the retarded diffusion or exclusion of the photosensitizer, imposed by the presence of 
the EPS, we tested the susceptibility of disrupted biofilms to aPDT. Resuspended 
biofilm cells (which presumably have lost most of their EPS) were less resistant to 
aPDT with XF-73 than intact biofilms. The disruption of the biofilm structure improved 
the accessibility of the biofilms to aPDT, suggesting that the organized structure of 
biofilm might play a role in the susceptibility of intact biofilm to antimicrobial drugs. It 
is also likely that the disruption of the biofilm structure provides new access to nutrients 
to the cells, which were previously starving in deep layers of the biofilm. This brings 
them back to the susceptible state of exponential growth [151]. 
The challenge in aPDT is to find a therapeutic window, in which 
microorganisms are killed without harming the surrounding tissue. Maisch et al. 
evaluated the phototoxicity of XF-73 against bacterial cells and found that, the 
parameters able to cause 3 log10 killing in a range of Gram-positive staphylococcal 
strains, including methicillin-resistant Staphylococcus aureus (MRSA) strains, were not 
toxic for human fibroblasts or keratinocytes, with ≥ 90% of these cells still viable in 
vitro. Furthermore, fluorescence microscopy images showed that XF-73 is located 
outside of the nucleus, in the mitochondria of mammalian cells [45].. This finding 
corroborates the fact that PDT has a low mutagenic potential, since singlet oxygen, the 
main cytotoxic agent produced in photodynamic action, has a short life time in cells, 
less than 0.05 ps. Thereby, singlet oxygen, can diffuse less than 0.02 pm from the site of 
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its generation, reducing the possibility of nuclear damage [51]. The absence of 
genototoxic and mutagenicity to human cells is a must have of APDT that favors its 
long-term safety. 
In a later study, fluorescence experiments showed that the distribution of the 
formulation XF-73 water-ethanol was restricted to the stratum corneum and no 
accumulation in deeper parts of the epidermis or dermis was observed, even with an 
incubation time of 4 h, which is the same incubation time that we have used to kill 
biofilm cells [45]. Localization of XF-73 in the stratum corneum indicates the existence 
of a therapeutic window for an efficient decolonization of pathogens without side 
effects for the underlying tissue. PSs, which penetrate only the stratum corneum, may 
be used for the treatment of Candida infections, since the most common type of 
infections, caused by Candida species, are superficial infections of skin and mucous 
membrane, which do not affect living tissues [152]. Therefore, successful treatment of 
superficial infections by C. albicans has the advantage to avoid that this microorganism 
reaches the bloodstream infecting internal organs. 
In this study the action of AmB, the drug of choice for treating severe systemic 
infection, was also compared with the action of aPDT, against both cell phenotypes of 
C. albicans. Antifungal drugs, like AmB, act according the key-lock principle. This 
means, that they have specific action against a single component of the cell. In the case 
of AmB, this component is ergosterol, which is located in the cell membrane. On the 
other hand, aPDT acts via multihit processes, where all the putative targets in the cell 
are available to be damaged by the ROS, formed during the photodynamic process.  
The minimum inhibitory concentrations (MIC) for AmB range from 0.06-2.0 µg 
mL-1 for planktonic cells [153]. In the present study, it was not possible to kill C. 
albicans planktonic cells, when they were treated with AmB for the same time period as 
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aPDT (30 min). But, when planktonic cells were treated with AmB for 24 h, it was 
possible to kill planktonic cells using 2.5 µg mL-1 of AmB. C. albicans isolates with 
MIC ≧ 2 µg mL-1 are already considered to be resistant [154]. On the other hand, 
biofilms could be killed in both treatment conditions (5 and 24 h) with concentrations of 
10 µg mL-1 and 50 µg mL-1 of AmB. These AmB concentrations are higher than the 
serum levels (0.5 to 2.0 µg mL-1), used to treat patients with infections, caused by C. 
albicans and can be toxic to human cells [142, 155]. Compared to the conventional 
AmB treatment, aPDT was more effective. Furthermore, the damage, caused by aPDT, 
occurs only when light activates the drug and elicits the toxic action. 
The local action of AmB to osteoblasts and fibroblasts was recently investigated. 
This investigation showed that 100 and 1000 µg mL-1 of AmB caused osteoblast cell 
death and 1 to 10 µg mL-1 caused sublethal toxicity to osteoblasts and fibroblasts. If 
local concentrations of 100 to 1000 times of the MIC are necessary to treat infections, 
caused by biofilms, cell toxicity at the site of the treatment should be considered [156].  
For the first time, 1O2 was detected in biofilms of C. albicans, indicating that this 
ROS was responsible for the TMPyP/XF-73 photodynamic damage to C. albicans 
biofilms cells. 1O2 luminescence was detected after both PSs were washed away from 
the biofilms. This fact suggests that both PSs were able to penetrate the biofilm 
structure, since 1O2 was generated by PSs, which were within the biofilm and not in the 
external milieu (supernatant). The luminescence intensity, detected for incubation with 
XF-73, is higher compared to TMPyP, which might be due to better attachment of XF-
73 to the cells or the biofilm EPS. This is in agreement with the toxicity data, where a 
smaller amount of XF-73 is needed for the same toxic efficacy.  
The results obtained in this study showed that XF-73 is a very effective PS, which 
is able to kill even C. albicans cells in the biofilm state, using very small concentrations 
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of the PS and low light doses that justify further investigations of XF-73 mediated 
aPDT in particular in clinical studies.  
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3 Photodynamic inactivation of Candida 
albicans coaggregated with Staphylococcus 
epidermidis in a duo-species biofilm 
3.1 Introduction 
Candida albicans biofilms can consist of a single microbial species or multiple 
microbial species. Although several infections are caused by biofilm formed solely by 
C. albicans, biofilm formed by C. albicans and other bacteria are predominant [157, 
158]. In a biofilm formed by multiple microbial species which are closely associated, 
mutually beneficial interactions may arise. Candida species of mixed biofilms are often 
found with bacterial cells and are subjected to various antagonistic and synergistic 
interactions which may impact the virulence of C. albicans [159, 160]. For instance, 
Pseudomonas aeruginosa can be co-isolated with C. albicans thereby Pseudomonas can 
further adhere, lyse and kill C. albicans hyphae [161, 162]. On the other hand, C. 
albicans has a synergistic relationship with Streptococcus gordonii. It was showed that 
this bacteria enhances C. albicans filamentation, whereas C. albicans stimulates biofilm 
formation of Streptococcus gordonii [163]. Furthermore, the ability that C. albicans has 
to switch from a yeast to a hyphal morphology provide an invasion strategy to other 
microbial cells, like staphylococci, which are known to adhere in C. albicans hyphae 
[164]. 
3 Photodynamic inactivation of Candida albicans coaggregated with 
Staphylococcus epidermidis in a duo-species biofilm 
64 
 
A study investigating the presence of fungal pathogens in biofilms causing 
chronic wounds found that 3% of these wounds were positive for fungal species, 
predominantly Candida sp. which was responsible for > 50% of the microbial burden in 
the wounds [165]. Such polymicrobial biofilms are more extremely difficult to treat 
because they require a drug with activity against both fungi and bacteria cells [166].  
Staphylococcus epidermidis is a commensal skin bacteria, but can cause severe 
infection after invasion and penetration of both epidermal and mucosal barriers [167]. 
Whereas C. albicans is by far the most frequently fungal pathogen found in biofilms, 
the most prevalent isolated bacterial species is S. epidermidis. In addition, this bacteria 
is the most frequent cause of nosocomial infections [168]. In patients with candidemia, 
S. epidermidis is the most commonly bacteria specie isolated [169]. 
Therefore, it was investigated the susceptibility of C. albicans co-isolated with S. 
epidermidis to XF-73-mediated aPDT. This result was compared with the results 
obtained in the first section, where we tested the photoactivity of XF-73 against C. 
albicans monomicrobial biofilm. 
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3.2 Materials and Methods 
3.2.1 Strains of C. albicans 
One to three colonies of C. albicans (ATCC-MYA-273, LGC Standards GmbH, 
Germany) were picked up from agar plates with a sterile inoculating loop and 
transferred to a culture tubes containing 5 mL of Sabouraud Dextrose Broth (SDB) 
(Sigma Chemical Co., St. Louis, Mo) and grown at 37 °C on a shaker platform (200 
rpm) overnight. When the cultures reached the stationary phase of growth, the cells 
were harvested by centrifugation (3100 rpm, 5 min), washed once with Dulbecco's 
phosphate-buffered saline (PBS without Ca2+ and Mg2+; PAA Laboratories GmbH, 
Austria) and used for further experiments. 
3.2.2 Strains of S. epidermidis strains 
One to three colonies of S. epidermidis (ATCC-35984) (Gentamycin-susceptible strain) 
(LGC Standards GmbH, Germany) were picked up from agar plates with a sterile 
inoculating loop and transferred to a culture tubes containing 5 mL of in Tryptic soy 
broth (TSB) (Sigma-Aldrich-Fluka, St Louis, USA) and grown at 37 °C on a shaker 
platform (200 rpm) overnight. When the cultures reached the stationary phase of 
growth, the cells were harvested by centrifugation (5.000 rpm, 5 min), washed once 
with PBS and used for further experiments. 
3.2.3 Photosensitizer and light source 
The photosensitizer used in this study was XF-73. The irradiation of samples was 
performed using an incoherent light source (Omnicure Series 2000, igb-tech, 
Friedelsheim, Germany) with an excitation filter set of 400–500 nm. This light source 
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was used because it has a higher light intensity (49.8 mW cm-2) than the light used to 
photoinactivate C. albicans monomicrobial biofilms (section 2; 13.4 mW cm-2). 
Therefore the overall period treatments could be shortened. 
3.2.4 Formation of duo-species biofilm 
As C. albicans readily forms monomicrobial biofilms in serum, duo-species biofilm 
formed by C. albicans and S. epidermidis were also formed in this medium. Different 
parameters were tested to find the optimal condition for duo-species biofilm formation. 
The following conditions were tested: S. epidermidis was added to the microplates 
concurrently, 2 h, 4 h and 6 h after the addition of C. albicans. The concentration of C. 
albicans added to the microplates in relation to S. epidermidis was 1:1, 1:10, 1:40. As 
C. albicans readily forms monomicrobial biofilms in serum, polymicrobial biofilms 
formed by C. albicans and S. epidermidis were also formed in this medium. 
Polymicrobial biofilms used in the experiment were formed as following: the 
concentration of C. albicans added to the microplates in relation to S. epidermidis was 
1:40. Accordingly, C. albicans cells were diluted to 106 cells mL-1 in 25% of FBS and 
200 µL were added to sterile flat-bottomed 96-well polystyrene plates 6 h before the 
addition of S. epidermidis. S. epidermidis (5 µL) were diluted in TSB to an optical 
density at 600 nm (OD600) of 0.5, corresponding to 108 cells mL-1. Then they were 
added to the wells and mixed by pipetting up and down. The plates were incubated for 
36 h at 37°C. To monitor the bacterial and fungal growth within the biofilms, CFU 
assay using selective plates was used to assess fungal versus bacterial numbers. 
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3.2.5 Multi-channel 3D fluorescent microscopy images 
Duo-species biofilms were formed as described before, using cell culture dishes of size 
35×10mm (Cellstar, Frickenhausen, Germany). Biofilms were stained with a nucleic 
acid intercalator membrane-permeable, the Syto-9 green-fluorescent (Molecular Probes, 
Eugene, OR, USA), which stain microbial cells in green. Additionally, Concanavalin A 
(ConA)-Texas Red conjugate (Molecular Probes, Eugene, OR, USA) was used to stain 
the biofilm EPS in red. The final concentrations of dyes were as follows: 0.01 mM for 
Syto-9 and 200 µg mL-1 for ConA. 
Fluorescence microscopy was performed using a Zeiss Observer Z1 inverted 
fluorescence microscope with ApoTome (Zeiss) and AxioVision software (v 4.6.2.0, 
Zeiss) using appropriate filter-sets for excitation and emission of SYTO 9 
(λex485nm/λem500nm) and Con A (λex590nm/λem615nm). 
3.2.6 Photodynamic inactivation of C. albicans co-isolated with S. 
epidermidis 
After 36 h of incubation, biofilms were washed once to remove loosely attached cells. 
The cells were incubated with increasing concentrations of XF-73 (0; 0.1; 1; 10 and 100 
µM) for 4 h in the dark at 37°C. Thereafter, cells were illuminated for 16.6 min (50 J 
cm-2). The maximal fluence rate at the level of the irradiated samples was 49.8 mW cm-
2
. Biofilms were then detached from the bottom of the well by scraping the bottom of 
the microplate with a pipette tip and transferred to an eppendorf tube containing 1 mL 
of PBS. Biofilm material scraped from the wells was homogenized by vortexing and 
sonicating, each for 1 min to get single cells prior a CFU assay was done. 
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3.2.7 Colony forming unit assay 
Miles and Misra method was used to estimate the viable number of microbial cells after 
phototoxic treatments [170]. After ten-fold serial dilutions of cell suspensions in PBS, 3 
x 20 µl of the dilutions were seeded onto Sabouraud Dextrose Agar supplemented with 
Gentamicin (0.005 mg mL-1) for selective recovery of C. albicans and 0.1 ml onto 
Tryptic Soy Agar supplemented with AmB (0.5 mg mL-1) for selective recovery of S. 
epidermidis, for 48 h at 37°C. A CFU assay was done to determine the number of 
colony forming unites per milliliter. 
3.3 Results 
Since Candida sp. are often found coaggregated with bacteria in polymicrobial biofilms 
in vivo and the susceptibility of these fungal cells to antifungal agents can be modulated 
by bacterial cells present in the polymicrobial biofilm, it was determined whether C. 
albicans and S. epidermidis could form polymicrobial biofilms in vitro and whether this 
interaction could affect the susceptibility of C. albicans to aPDT. 
3.3.1 Formation of duo-species biofilm 
From the different parameters tested, the best conditions to generate a duo-species 
biofilm formed by C. albicans and S. epidermidis were the following: C. albicans 106 
cells mL-1 diluted in 25% of fetal bovine serum (FBS; PAN Biotech, Aidenbach, 
Germany) and added to the microplates 6 hours before the addition of S. epidermidis 
(OD of 0.5, corresponding to 108 cells mL-1). According these conditions, fungal cells 
could first attach to the surface of the microplates, undergo yeast-to-hyphal transition, 
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due to the presence of FBS. S. epidermidis added 6 hours later could adhere to C. 
albicans hyphaes. With these parameters it was possible to recovery 107 cells mL-1 for 
C. albicans cells and 1011 cells mL-1 for S. epidermidis. 
3.3.2 Multi-channel 3D fluorescent microscopy images 
To confirm the presence of the EPS, the duo-species biofilm was stained with ConA-
Texas Red conjugate, which stained the EPS in red (Fig. 36). SYTO 9 penetrates all 
microbial membranes and stained microbial cells in green. Green colored area shows C. 
albicans hyphae associated with microcolonies of S. epidermidis. It seems that C. 
albicans acted as a scaffold for the attachment and proliferation of S. epidermidis (Fig. 
36). 
 
Fig. 36 Fluorescence image of C. albicans-S. epidermidis biofilm: 24 h biofilms were stained 
with Syto 9, which stained hyphae of C. albicans and S. epidermidis in green and ConA-
Texas Red conjugate which stains the EPS in red (20× objective). 
matrix
matrix
C.  albicans  hyphae
C.  albicans  hyphae
S. epidermidis attached to
hyphae
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3.3.3 Photodynamic inactivation of C. albicans co-isolated with S. 
epidermidis 
The photodynamic efficacy of XF-73 in combination with blue light was investigated 
against C. albicans found as a part a duo-species biofilm of C. albicans and 
Staphylococcus epidermidis. These results where compared with the photoaction of XF-
73 against C. albicans monomicrobial biofilms obtained in the first section.  
C. albicans co-isolated with S. epidermidis showed increased resistance to XF-73 
mediated aPDT even with higher concentrations of XF-73. Even concentrations as high 
as 100 µM of XF-73 did not cause any decrease in C. albicans survival (Fig. 37). C. 
albicans monomicrobial biofilms incubated with 1 µM of XF-73 for 4 h and illuminated 
with for 60 min (13.4 mW cm-2, 48.2 J cm-2) yielded 5 log10 decrease cell survival 
(section 2.3.4, Fig. 27). Overall, the results showed that bacteria can affect the 
susceptibility of C. albicans to aPDT in the duo-species biofilm. 
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Fig. 37. APDT treatment of C. albicans coaggregated with Staphylococcus epidermidis in a 
duo-species biofilm. Duo-species biofilm were grown on the surface of 96 well plates for 36 
h. After incubation with different concentrations of XF-73 for 4 h, the samples were 
irradiated with 49.8 mW cm-2, 50 J cm-2. A CFU assay was performed immediately after 
aPDT, and surviving colonies were counted 24 h later. Black dashed line: baseline 
CFU/ml; green dashed line: reduction of 3 log10 steps in viable C. albicans (reduction 
99.9%); red dashed line: reduction of 5 log10 steps in viable C. albicans (reduction 
99.999%). (n = 3 experiments; median ± interquartile range). The arrow marks the lower 
detection limit of the CFU assay. 
3.4 Discussion 
It is estimated that 27-56% of C. albicans bloodstream infections are 
polymicrobial [169]. The most commonly co-isolated bacterial species is 
Staphylococcus epidermidis [169]. Previous study already showed that C. albicans and 
S. epidermidis can extensive interact in a duo-species biofilm and that they had altered 
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their antimicrobial susceptibility when growing as a part of a duo-species biofilm. The 
EPS produced by S. epidermidis inhibit fluconazole penetration and C. albicans 
enhanced the growth of S. epidermidis and increased the resistance of S. epidermidis to 
vancomycin [159].  [159]. Therefore, we investigated whether C. albicans and S. 
epidermidis could form polymicrobial biofilms and the effect of S. epidermidis on the 
susceptibility of C. albicans to aPDT within the polymicrobial biofilm.  
In accordance with already published data [159, 164], it was established a duo-
species biofilm formed by C. albicans and S. epidermidis, where the bacteria were 
attached to the hyphal filaments of C. albicans. Biofilm formation by C. albicans mixed 
with bacteria occurs in a temporal manner such that the attachment of C. albicans 
becomes the scaffolding to which other microbial specie may adhere. As a result, the 
composition of early colonizers determines which microbes colonize at later time points 
of biofilm formation. This process of sequential attachment is commonly referred to as 
coaggregation [164]. 
Compared with C. albicans monomicrobial biofilm in the section 2, C. albicans in 
the polymicrobial biofilm was resistant to aPDT. In the section 2.3.4, C. albicans 
monomicrobial biofilms incubated with 1 µM of XF-73 for 4 h and illuminated with for 
60 min (13.4 mW cm-2, 48.2 J cm-2) yielded 5 log10 decrease cell survival. Here, C. 
albicans in the polymicrobial biofilm, could not be photokilled even using 
concentrations as high as 100 µM.  Also, the light sources used in both experiments 
were different. Despite the same overall light doses were used in both experiments 
(monomicrobial×polymicrobial), the light intensity used to activate the PSs in the 
experiments with polymicrobial biofilms was higher (49.8 mW cm-2) versus 13.4 mW 
cm-2. 
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The increased resistance of C. albicans coaggregated with S. epidermidis when 
compared to C. albicans within a monomicrobial biofilm might be explained by the fact 
that a polymicrobial biofilm produces more EPS than a monomicrobial biofilm. Another 
study investigated the effects of aPDT using MB (0.1 mg mL-1) and red light (100 mW 
cm-2 and 350 J cm-2) on the viability of a polymicrobial biofilm formed by C. albicans, 
S. aureus and Streptococcus mutans. Single-species biofilm (2.32–3.29 log10) were 
more susceptible to aPDT than the mixed-species biofilm (1.00–2.44 log10) formed by 
two and three species of microorganisms, suggesting that the more complex the 
composition of the biofilm, the more resistant it seems to be to aPDT. The authors 
suggested that the interactions between the different EPS polymers in these 
polymicrobial biofilms, produces a more viscous EPS, increasing the antibiotic 
resistance further [172]. 
Polymicrobial biofilms are usually thicker and more stable than monomicrobial 
biofilms [173]. Recently it was demonstrated that the total biomass of a polymicrobial 
biofilm formed by C. albicans and S. aureus were greater than the biomass of each 
microorganism growing independently as a biofilm [174]. Such an increased biomass in 
a polymicrobial biofilm may enhance resistance to antimicrobial treatments. 
Another point is the fact that the biofilm used in this study was older (36 h) than 
in the monomicrobial biofilm (24 h). The age of the biofilms might also affect it 
susceptibility to antimicrobial treatments. Young biofilms have a less organized 
structure, a more active metabolism and a less pronounced stress response than more 
mature biofilms [175]. Like that, young biofilms seems to be more susceptible to 
antimicrobial treatments than older biofilms. In contrast, some photodynamic studies 
already showed that aPDT is more effective in inactivating older biofilms than younger 
ones. MB mediated aPDT was more effective to inactivate a 48 h old biofilm of 
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Pseudomonas aeruginosa (>99.999%) than a 24 h old one (99.9%). P. aeruginosa 
produces larger amounts of phenazine compounds (endogenous PSs) when they are in 
the stationary phase, since phenazine is regulated by quorum sensing and produced 
under conditions of high cell density and nutrient limitation, which are the conditions 
present in more mature biofilms. P. aeruginosa secretes enzymes and EPS components 
that protect it from the harmful effects of its own endogenous PSs; however upon 
addition of an exogenous PS, their natural mechanisms of protection may become 
saturated, leading to the photodynamic killing of the cells. So, the authors stated that it 
seems that the synthesis and accumulation of higher amounts of phenazines in older 
biofilms than in younger ones would lead to a greater additive effect of the two PSs and 
result in enhanced bactericidal activity [176]. Another study also using MB as a PS, 
showed that “older” Streptococcus mutans biofilms were more susceptible to aPDT than 
“younger” biofilms. Two hypotheses were used to explain the increased resistance of 
younger biofilms to aPDT: Firstly, the channel architecture of mature biofilms 
permitted enhanced access for the PS within the biofilms. Secondly, younger biofilms 
are metabolically more active and are better able to repair damage mediated by ROS 
[177]. More studies to elucidate whether the biofilm age plays an important role in the 
susceptibility of microbial cell to aPDT are necessary. 
Data obtained from the present study showed that the more complex the 
composition of biofilm is, the more resistant it seems to be to aPDT. If the EPS is 
responsible for the increased resistance of C. albicans in a polymicrobial biofilm when 
compared to the monomicrobial biofilm, an approach is necessary to weaken the EPS of 
a biofilm. Therefore an alternative strategy could be the combination of Polymixin B or 
EDTA with aPDT. Polymixin B and EDTA both agents are able to destroy bridges 
formed between divalent cations (calcium and magnesium) and negatively charged 
3 Photodynamic inactivation of Candida albicans coaggregated with 
Staphylococcus epidermidis in a duo-species biofilm 
75 
 
polysaccharides in the biofilm EPS structure [178]. Like that is possible to disrupt the 
3D-biofilm structure and consequently give access to the antimicrobial effects of aPDT. 
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4 Analysis of Candida albicans heat shock 
response to photodynamic inactivation-
mediated oxidative stress 
4.1 Introduction 
The induction of heat shock proteins (Hsps) represents a potent response to oxidative 
stress [179]. Hsps were first identified by their elevated expression following 
hyperthermic cell stress. They are a highly conserved ubiquitously expressed family of 
stress response proteins which is expressed at low levels under normal physiological 
conditions [180]. However, in response to cellular stress, such as an elevation in 
temperature, oxidative stress or starvation - the expression of Hsps increases 
dramatically. These proteins have protective functions, and play a role in normal growth 
and development [181].  Hsps is involved in folding/unfolding of proteins, assembly of 
multiprotein complexes, transport/sorting of proteins into correct subcellular 
compartments, and protection of cells against stress/apoptosis [53, 180, 182]. 
The Hsp70 family is the most abundant and conserved class of stress proteins and 
is considered a potential biomarker of cellular toxicity, being upregulated in response to 
a wide range of important environmental and physiological stresses [183-185]. Hsp70 
expression causes inhibition of stress-induced caspase activation and downstream 
events in the apoptotic cell death pathway [171]. Hsp70 is capable of binding and 
sequestering activated caspases in addition to its important functions in protein 
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refolding and transport, proteolytic degradation of unstable proteins, and control of 
regulatory protein activity [114, 183, 186, 187]. 
In response to the oxidative damage induced by aPDT, microbial cells might 
initiate a rescue response to allow cells to deal with the damage produced by stress. 
However in aPDT, the importance of cellular rescue responses is not clarified for most 
cellular systems and photosensitizers [179]. Therefore this study investigated whether 
the oxidative damage caused by TMPyP-aPDT can induce Hsp70 production in C. 
albicans and whether Hsp70 induced by thermal insult in C. albicans cells exerts a 
protective effect against aPDT. 
4.2  Material and Methods 
4.2.1 Strains of C. albicans 
One to three colonies of C. albicans (ATCC-MYA-273, LGC Standards GmbH, 
Germany) were picked up from agar plates with a sterile inoculating loop and 
transferred to a culture tubes containing 5 mL of Sabouraud Dextrose Broth (SDB) 
(Sigma Chemical Co., St. Louis, Mo) and cultured overnight. When the cultures reached 
the stationary phase of growth, the cells were harvested by centrifugation (5000 rpm, 5 
min) and washed once with Dulbecco's phosphate-buffered saline (PBS without Ca2+ 
and Mg2+; PAA Laboratories GmbH, Austria). For experiments with planktonic cells, 
approximately 5×107 cells mL-1 were prepared in PBS.  
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4.2.2 Photosensitizer and light source 
The photosensitizer used in this study was TMPyP, a standard PS used in aPDT, already 
known to be effective against C. albicans planktonic cells and a potent singlet oxygen 
generator. The irradiation of samples were performed using an incoherent light source 
(UV236) λem = 418 ± 20 nm).  The maximal fluence rate at the level of the irradiated 
samples was 13.4 mW cm-2. Cells were irradiated for 15 min (total light dose: 12.1 J cm-
2). 
4.2.3 Heat shock induction prior aPDT 
To investigate whether the overexpression of Hsp70 would protect C. albicans cells 
from the oxidative damage caused by aPDT, cells adjusted at 5×107 cells mL-1 were 
resuspended in 5 mL of SDB and exposed to 37 °C or heated in a water bath at 45 °C 
for 20 min (preheat treatment) (an optimum temperature for the heat-shock response in 
C. albicans) [188]. Prior phototoxic experiments, cells were centrifugated and 
resuspended in PBS, since the nutrients present in the culture medium can reduce the 
efficiency of aPDT. Then proteins from cells heat shocked were extracted and analyzed 
to ensure Hsp70 overexpression (control) and simultaneously phototoxic experiments 
were done. 
4.2.4 Phototoxic experiments with cells pretreated at 37 °C or 45° C 
Cells exposed to 37 °C or heated at 45 °C for 20 min were incubated for 15 min with 
different concentrations of TMPyP (0 to 5µM) and irradiated with a light dose of 12.1 J 
cm-2. Viable C. albicans cells were accessed by CFU assay. 
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4.2.5 Kinetics of the Hsp70 expression process in response to sublethal 
doses of aPDT 
In order to determine whether aPDT caused an overexpression of Hsp70 in C. albicans, 
cells were exposed to a sublethal aPDT dose. For this, C. albicans cells were incubated 
with 1 µM of TMPyP for 15 min and irradiated with a light dose of 12.1 J cm-2. These 
conditions caused ~1 log10 decrease in cell survival, in order to stress the cells, without 
completely killing them. These conditions were based in the phototoxic experiments 
from section 2.3.3 figure 24, where it was tested the photoaction of TMPyP against C. 
albicans planktonic cells. Following, cells were centrifugated and resuspended in SDB 
and harvested at 0, 30 min, 1 h, 2 h, 4 h, 8 h, 12 h and 24 h after aPDT exposure. The 
protein extracts were then analyzed for Hsp70 expression by Western blot.  
4.2.6 C. albicans protein extraction 
Cells were subjected to disruption after suspending in yeast-Protein extraction reagent 
(Y-PER®, Thermo Scientific, Rockford, IL, USA). 250 mL of lysis buffer per 50 mg of 
wet cell pellet were added and additional 4 g of glass beads per 1 g of wet cell pellet 
were used. Cells were subjected to disruption 5 times, each time for 1 minute with an 
interval of 1 min of incubation in ice. At the end of the procedure, the pellet debris was 
centrifugated at 10,000 rpm for 10 min at 4°C.  The supernatant was reserved for further 
analysis. 
4.2.7 Protein determination by the BCA method 
After proteins were extracted, protein concentration was determined by the 
bicinchoninic acid (BCA) assay (Thermo Scientific, Rockford, IL, USA). The BCA 
assay relies on two reactions. Fistly, protein reduces Cu2+ ions from the cupric sulfate to 
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Cu1+. Next, BCA reacts with the newly formed Cu1+ ions to form a purple coloured 
BCA-Cu1+ complex that has an absorbance at 562 nm [189]. The protein content of 
unknown samples was determined spectrophotometrically by comparison with known 
diluted protein standards (albumin) (0; 0,1; 0.5; 1 and 2 mg mL-1). 
4.2.8 Sodium Dodecyl Sulfate – Poly Acrylamide Gel 
Electrophoresis (SDS – PAGE) 
SDS-PAGE was carried out using Mini-Protean II (Bio-Rad,City, CA, USA). Protein 
extracts (2 µg total proteins per sample) were treated with reducing Laemmli buffer 
[190] and boiled at 95° C for 5 min for complete denaturation. 10 µL of cells lysates per 
lane (2 µg), 5 µL of prestained protein ladder (Thermo Scientific, Rockford, IL, USA) 
and 5 µL of a positive control recombinant protein (0,075 µg) HSP70/HSP72 (ADI-
SPP-758-D, Enzo Life Sciences, Lörrach, Germany) were loaded and separated on 8% 
polyacrylamide SDS-PAGE gels by electrophoresis. The gel was run at 0.03A for initial 
15 min until the samples travel through the stacking gel. Then, the current was turned to 
0.04A until the bromophenol blue reached the anodic border of the separating gel. 
4.2.9 Western blotting 
After separating the proteins according to their molecular mass by SDS-PAGE, proteins 
were electrophoretically transferred to a nitrocellulose membrane (Hybond™-C Extra, 
Amerscham Biosciences, New Jersey, USA) for 50 min at 0.3 A using the SD Semi-dry 
Transblot Apparatus (Bio-Rad, Hercules, USA). To ensure transfer is complete, the 
membrane was stained with 0.1% w/v Ponceau-S in 5% acetic acid.  Following, the 
membrane was destained by repeated washing in Tris-Buffered Saline-Tween (TBS-T; 
Bio-Rad, California, United States) with 0.5% Tween 20 (Carl Roth GmbH & Co, 
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Karlsruhe, Germany)] and blocked with fresh 5% milk (Magermilchpulver, Saliter 
MMP, Obergünzburg, Germany) in TBS-T for 1 h at room temperature. After bathing in 
blocking buffer to reduce unspecific binding, the membrane was rinsed 3 times for 5 
min. each time with TBS-T. The membrane was incubated overnight with a primary 
monoclonal mouse antibody against HSC70/HSP70 (ADI-SPP-758-D; Enzo Life 
Sciences, New York, USA) diluted at 1:1000 in fresh 1% (w/v) nonfat dry milk in TBS-
T, overnight at 4°C. After rinsing the membrane to remove unbound primary antibody, 
the membrane was again washed (3 washings for 5 min) and incubated with 
corresponding secondary antibody bound to horseradish peroxidase (HRP) anti-mouse 
IgG (Cell Signalling Technology, MA, USA) and diluted at 1:1000 in fresh 1% (w/v) 
nonfat dry milk in TBS-T, for 1 h in room temperature. After 3 washes of 5 minutes 
each with TBS-T, the membrane was incubated with ECL chemiluminescent substrate 
(Pierce ECL Western Blotting Substrate, Thermo Scientific, Rockford, USA). Equal 
volumes of reagent A (luminol) and reagent B (an enhancer) were mixed and the blot 
was incubated in this solution for 1 minute. The blot was immediately exposed to an X-
Ray film (Amersham HyperfilmTM ECL, GE Healthcare limited, Buckinghamshire, UK) 
in the dark for varying periods of time ranging from 5 sec to 5 min and the reactive 
proteins were visualized after automatic development on an X-ray developing machine 
(Kodak M35, OMAT Processor, Stuttgart, Germany). To control the total protein load, 
the membrane was incubated with anti-GAPDH polyclonal antibody conjugated to HRP 
from rabbit (ab9385; Abcam, Cambridge, UK) diluted at 1:1000 with fresh 5% milk 
overnight at 4°C and  with secondary antibody anti-rabbit  IgG, HRP linked (Cell 
Signalling Technology, Massachusetts, USA), diluted at 1:1000 in fresh 5% milk. The 
signal intensities of western blot bands were analyzed by the software ImageJ [191] and 
the relative grey scale intensities of the samples were compared with the untreated 
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controls. The signal intensities were normalized to the corresponding GAPDH controls 
per each lane before calculating their ratios. The calculations of the signal intensities 
were done relatively towards the appropriate control protein band (untreated sample at 
37°C), which was set as 1 (or 100%). 
4.2.10 Colony forming unit assay 
The Miles and Misra method was used to estimate the viable number of C. albicans 
cells after phototoxic treatments (see section 3.2.7) [170]. After ten-fold serial dilutions 
of cell suspensions in SBD, 3 x 20 µl were seeded onto SDA. A CFU assay was done to 
determine the number of colony forming unites per milliliter. 
4.3 Results 
4.3.1 Heat shock induction 
To ensure that C. albicans cells were able to start a heat shock response, cells were pre 
heated for 20 min at 45° C, an optimum condition for the heat-shock response in C. 
albicans, and protein extracts were analyzed and compared with the protein extracts 
from cells kept at 37 °C (control). Cells heat shocked (45 °C) showed an increase in 
Hsp70 concentrations in comparison to cells left at 37 °C, as determined by the Western 
blot (Fig. 38 A). 
Quantification of Western blot signals revealed that Hsp70 was 2.9 folds more 
induced in heat shocked cells (45° C) than in control ones (37° C) (Fig. 38 B). 
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Fig. 39. C. albicans planktonic cells kept at A) 37 °C and B) 45 °C and subsequently 
submitted to aPDT. C. albicans planktonic cells were incubated with different 
concentrations of TMPyP for 15 min, the samples were irradiated with 12.1 J cm-2. A CFU 
assay was performed immediately after aPDT, and surviving colonies were counted 24 h 
later. Black dashed line: baseline CFU/ml; green dashed line: reduction of 3 log10 steps in 
viable C. albicans (reduction 99.9%); green dashed line: reduction of 5 log10 steps in viable 
C. albicans (reduction 99.999%). (n = 3 experiments; median ± interquartile range). The 
arrows mark the lower detection limit of the CFU assay. 
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4.3.3 Kinetics of the Hsp70 expression process in response to sublethal 
doses of aPDT 
C. albicans were incubated for 15 min with 1 µM of TMPyP and irradiated with a light 
dose of 12.1 J cm-2, suffered ~1 log10 decrease in cell survival (Fig. 40), indicating that a 
mild oxidative stress was induced inside the cells. Higher PS concentrations caused 
increased cell death, making the synthesis of protein not feasible, including heat shock 
proteins. 
 
Fig. 40. Determination of sublethal condition of aPDT against C. albicans planktonic cells. 
Phototoxicity of TMPyP against C. albicans planktonic cells. C. albicans planktonic cells 
were incubated with different concentrations of TMPyP for 15 min, the samples were 
irradiated with 12.1 J cm-2. A CFU assay was performed immediately after aPDT, and 
surviving colonies were counted 24 h later. Blue arrow shows the reduction of ~1 log cell 
survival caused by aPDT using 1 µM of TMPyP. (n = 3 experiments; median ± 
interquartile range). The arrows mark the lower detection limit of the CFU assay. 
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light. (1) represents: 1 µM of TMPyP (proteins extracted from C. albicans which were 
treated with 1 µM of TMPyP and either kept in the dark or exposed to the light. 
4.4 Discussion 
Hsps are rapidly induced in response to stress and likely play a major role in stress 
tolerance and cytoprotection [192]. However, the role of Hsp against oxidative damage 
is still a matter of debate, with some reports showing protection and others not [193]. 
A previous study showed that heat shock induction by preheat treatment prior 
TBO-mediated aPDT caused ~2 log10 less killing in Escherichia coli and ~4 log10 less 
killing in Enterococcus faecalis bacteria as compared to killing without prior heat 
treatment [194].  
However, not all investigations on heat shock proteins show protective effect after 
aPDT. In this study, it was investigated whether upregulation of Hsp70 in C. albicans 
by preheat treatment (45 °C for 20 min) could protect C. albicans cells against the 
oxidative damage caused by singlet oxygen generated by TMPyP-mediated aPDT. It 
was observed that upegulation of Hsp70 did not protect C. albicans cells against the 
oxidative stress of singlet oxygen generated by aPDT. There was no difference in 
susceptibility between C. albicans cells kept at 37 °C (control cells) or preheated 
samples. The response of C. albicans is dependent on the oxidative stress conditions 
and is probably that 2,9 fold increase in Hsp70 expression got after preheat treatment 
was not sufficient to induce protective effects in C. albicans cells. Furthermore, aPDT is 
a multi-hit oxidative process and is likely that Hsp 70 expression is not enough to 
protect cells againt photodynamic damage. 
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In this study it was also investigated whether TMPyP-mediated aPDT was able to 
induce Hsp70 overexpression. Hsp70 protein levels were analyzed after sub-lethal 
aPDT of C. albicans using the porphyrin derivative, TMPyP, an already known singlet 
oxygen generator, generating a quantum yield of 77% singlet oxygen [40]. Here in this 
study Hsp70 protein levels were measured at various time intervals after aPDT and they 
were not increased over a period of 24 h.  
For Escherichia coli bacterial strain, levels of Hsp60 (Groel) and Hsp70 (DnaK) 
were investigated after TBO-mediated aPDT. A 7-fold increase in Hsp60 and a 3-fold 
increase in Hsp70 were observed in E. coli after sub-lethal aPDT conditions [194]. 
Other studied showed that the expression of Hsp60 by Streptococcus mutans was also 
increased after a sub-lethal dose of aPDT with Rose Bengal, as well a singlet oxygen 
generator [61]. 
Responses to aPDT are related to both the PS which is used and the cell type 
which is treated by aPDT. The subcellular localization of the PS is of special 
importance, since it determines the localization of the primary damage. For example, 
hydrophobic PSs localize in the mitochondrial membranes and have there their its 
primary action [179]. For Hsp70 from mammalian eukaryotic cells, induction was most 
efficient in using PSs which localize preferentially in lysosomes. Like heat shock 
protein expression is a highly conserved stress defense mechanism in all eukaryotes 
[179], it is likely that the same happens to C. albicans. So far the intracellular 
localization of TMPyP is not known in Candida cells. 
An investigation tested three PSs from different classes: a chlorine (mono-L-
aspartyl chlorin-e6 [NPe6]), purpurin (tin etio-purpurin [SnET2] and a porphyrin PS 
(Photofrin [PH-II]), all of them singlet oxygen producers, were tested to investigate the 
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expression of Hsp70 in mouse tumor cells after photodynamic therapy (PDT). The 
results showed that the oxidative stress caused by singlet oxygen-PDT increased Hsp70 
mRNA and protein levels in mouse cells in vitro, depending on the PS used in the 
treatment. Hsp70 expression was observed after PDT using the chlorin and the purpurin 
PSs. Hsp70 protein levels remained elevated 24 h after PDT. PDT using the porphyrin 
PS did not induce Hsp70 expression. The authors hypothesized that the expression of 
Hsp70 in vitro is dependent on the cellular localization of the PSs. Target of PH-II-PDT 
are both the plasma membrane and mitochondria, whereas targets for NPe6- and 
SnET2-PDT are the plasma membrane and lysosomes. Like that, the Hsp response after 
PDT may be connected to differences in lysosomal versus mitochondrial damage [195]. 
However, in vivo PDT of the same mouse cells induced Hsp70 expression for all PSs 
tested, including Photofrin. It is likely that secondary effect of PDT besides direct 
cellular oxidation may be responsible to heat shock response observed after Photofrin 
mediated PDT of mouse cells in vivo [195]. 
These results showed for the first time that overexpression of Hsp70 by C. 
albicans cells is not a mechanism by which microbial cells might develop resistance to 
TMPyP-mediated aPDT and that the expression of Hsp70 in C. albicans did not 
increase after sub-lethal TMPyP-mediated aPDT. 
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5 Non-invasive optical monitoring of oxygen 
during photodynamic inactivation of Candida 
albicans and Staphylococcus epidermidis 
biofilm 
5.1 Introduction 
Luminescence based sensors for oxygen can be used to monitor the efficacy of an 
antimicrobial treatment, since molecular oxygen is an important indicator of cell 
viability [196, 197]. One of the advantages of optical oxygen measurement is the 
possibility to evaluate oxygen concentrations in a non-invasive way, not requiring 
physical contact between the sensor and the optical detector. These sensors can be 
integrated into biocompatible matrices such as polyethylene glycol or polyurethane 
hydrogels, which are non toxic to the culture medium. Furthermore, optical sensors can 
be easily miniaturized, are not easily contaminated, can be used as disposable sensors, 
and do not consume oxygen in their sensing process [198]. Disadvantages include poor 
long term stability due to photobleaching or leaching of the immobilized indicator, and 
that optical sensors measure the oxygen content in an environment rather than cell 
activities [199]. 
Optical oxygen sensors are based on the mechanism of luminescence quenching 
by ground state oxygen  (Fig. 42). When certain dye molecules (triplet emitters) absorb 
specific excitation light, they present long excited-state lifetimes emitting radiation at 
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longer wavelengths (phosphorescence). The excited triplet state of the dye can be 
quenched via colliding with oxygen molecules in their singlet ground states. Thereby, 
energy transfer from the excited indicator molecule to the oxygen molecules occurs. 
This results in a dye in its non-luminescent state and an electronically activated oxygen 
molecule that releases the energy in a manner that is not visible to the eye. This process 
is proportional to oxygen concentration [200]. The intensity of luminescence and its 
lifetime is then reduced with quenching. 
 
Fig. 42. Principle of oxygen dependent luminescence quenching. * represents excited states 
of the molecules. 
Oxygen concentration was monitored in a non-invasive way in C. albicans and S. 
epidermidis biofilms during aPDT using an optical oxygen sensor film. Knowing the 
concentration of oxygen during the aPDT process enables the measurement of cells 
viability and therefore the efficacy of the photodynamic process immediately during and 
after the aPDT without any time delay. 
h×v1 
h×v2 
5 Non-invasive optical monitoring of oxygen during photodynamic 
inactivation of Candida albicans and Staphylococcus epidermidis biofilm 
92 
 
5.2 Material and Methods 
5.2.1 Preparation of the oxygen sensor film 
The sensor films used in this chapter were prepared by Julia Cattani from the Institute of 
Analytical Chemistry, Chemo- and Biosensors of the University of Regensburg and 
described in details in her master thesis [201]. In short, the oxygen sensor (Fig. 43 A) is 
based on a luminescent probe, the porphyrin dye Platinum(II)-5,10,15,20-
tetrakis(2,3,4,5,6-pentafluorophenyl porphyrin [Pt-TFPP] (Fig. 43 B). In order to 
prepare a sensor cocktail for sensor fabrication, the dye was dissolved in 
tetrahydrofuran (THF) (2 mg mL-1 w/v) along with the hydrophobic polymer 
polystyrene (PS) (50 mg mL-1 w/v) as matrix material. The sensor cocktail is spread on 
a polyethyleneterephthalate foil via a knife-coating device. After evaporation of the 
THF, a 6 µm thick oxygen sensitive sensor layer is formed. Sensor spots are stamped 
out of the sensor foil. These spots are the either way glued onto the bottom of microtiter 
plates in order to grow the biofilm on the sensor spot or they are placed on top of a 
grown biofilm inside the microtiter plate wells. 
 
Fig. 43. A) Scheme of the oxygen sensitive sensor layer and B) Chemical structure of the 
oxygen dependent probe Platinum(II)-5,10,15,20-tetrakis(2,3,4,5,6-pentafluorophenyl 
porphyrin [Pt-TFPP] 
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5.2.2 Oxygen concentration measurement 
The oxygen consumption by biofilm cells was measured by detecting the luminescence 
of the dye sensor with a Tecan GENios Plus Microplate Reader multiwell microtiter 
plate reader (Tecan GENios ELISA reader; Tecan Group Ltd., Männedorf, Switzerland) 
at excitation/emission wavelengths of 405/635 nm. For the data evaluation, the intensity 
values of the luminescence emitted by the sensor placed in microplate wells containing 
biofilms submitted to different treatments (I) were divided by intensity values of the 
fluorescence emitted by the sensor alone, with no biofilm (blank values, I0) of the 
respective well to obtain I=I0. Wells containing biofilms (wells-biofilms) with 
microorganisms consuming oxygen give values higher than 1, due to the signal increase 
caused by less quenching of the fluorescent dye by oxygen. In cases where all the cells 
of a biofilm were dead, the theoretical value equals 1, according to the amount of 
ambient air oxygen. A total amount of 6 wells with grown biofilms per each condition 
were treated with the same concentration of either an antimicrobial drug, NaN3 or PS 
and the percentage of wells containing biofilm which were not consuming oxygen was 
calculated. Wells containing biofilms were classified as “breathing” (active biofilms) or 
not “breathing” (non actives biofilm). 
5.2.3 Placement of sensor in the microplate 
Oxygen sensors were placed in the wells of the microplates as following (Fig. 44 A and 
B): 
• Sensor was glued with high vacuum grease (medium; Merck KGaA, Darmstadt, 
Germany) at the surface of the wells of the microplate and the biofilm was formed 
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on its surface (sensor was located at the bottom of the biofilm) in 48/96 well 
microplates or  
• Sensor was placed on the top of the biofilm in 48 well microplates 
 
Fig. 44. Setup for oxygen measurement with sensor a) on the bottom of the biofilm and b) 
on the top of the microbial biofilm 
5.2.4 Strains of C. albicans 
One to three colonies of C. albicans (ATCC-MYA-273, LGC Standards GmbH, 
Germany) were picked up from agar plates with a sterile inoculating loop and 
transferred to a culture tubes containing 5 mL of Sabouraud Dextrose Broth (SDB) 
(Sigma Chemical Co., St. Louis, USA) and grown at 37 °C on a shaker platform (200 
rpm) overnight. When the cultures reached the stationary phase of growth, the cells 
were harvested by centrifugation (5000 rpm, 5 min) and washed once with Dulbecco's 
phosphate-buffered saline (PBS without Ca2+ and Mg2+; PAA Laboratories GmbH, 
Austria) and used for further experiments. 
5.2.5 Strains of S. epidermidis 
One to three colonies of S. epidermidis (ATCC-35984) (LGC Standards GmbH, 
Germany) were picked up from agar plates with a sterile inoculating loop and 
transferred to a culture tubes containing 5 mL of in Tryptic soy broth (TSB) (Sigma-
Aldrich-Fluka, St Louis, USA) and grown at 37 °C on a shaker platform (200 rpm) 
overnight. When the cultures reached the stationary phase of growth, the cells were 
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sensor
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sensor
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harvested by centrifugation (5.000 rpm, 5 min), washed once with PBS and used for 
further experiments. 
5.2.6 C. albicans biofilm formation 
For C. albicans biofilm formation, 106 cells mL-1 cells were diluted to 106 cells mL-1 in 
25% of FBS and 200 µL were added to sterile flat-bottomed 96-well polystyrene plates. 
Cells were then incubated at 37 °C for 24 h without shaking. Following biofilms were 
washed once with PBS to remove non-adhered cells and used for further experiments. 
5.2.7 S. epidermidis biofilm formation 
For S. epidermidis biofilm formation, cells were diluted in TSB to an optical density at 
600 nm (OD600) of 0.5, corresponding to 108 cells mL-1 and 200 µL or 500 µL were 
added to sterile flat-bottomed 96-well or 48 well polystyrene plates, respectively. The 
plates were then incubated for 36 h at 37 °C. Following biofilms were washed once with 
PBS to remove non-adhered cells and used for further experiments. 
5.2.8 Disrupted biofilms 
To compare the oxygen consumption between cells growing as a biofilm with cells 
disrupted from the biofilm, C. albicans biofilms were disrupted with the tip of a pipette 
after aPDT and before the sensor foil was placed on the top of the biofilm. In this way, 
it is likely that the cells have lost most of their EPS, since the EPS is the responsible to 
keep the organised structure of the biofilm and all the cells which originally formed the 
biofilm got in contact with the sensor. 
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5.2.9 Treatment of biofilms with antimicrobial drugs/sodium azide 
Penicillin-streptomycin (10.000 units of penicillin and 10 mg mL-1 of streptomycin in 
0.9% NaCl; Sigma-Aldrich, St Louis, USA) and sodium azide (NaN3, 99% purity, 
Acros Organics, New Jersey, USA) were used as a control to establish the set up to 
measure oxygen concentration of biofilms after antimicrobial treatment. Penicillin-
streptomycin is a combination of antibiotics used to prevent bacterial contamination of 
cell cultures, showing action against Gram-positive and Gram-negative bacteria, 
respectively. Sodium azide inhibits the respiratory enzyme cytochrome oxidase, and as 
a consequence cells are asphyxiated. 
Biofilms were then incubated with 100 µL (96 well microplates) or 500 µL (48 well 
microplates) of different concentrations of each drug. S. epidermidis biofilms were 
treated with 0; 1; 10; 100; 1000 and 5000 units of penicillin mL-1 together with 0; 
0.3125, 0.625, 1.25, 2.5 and 5 mg mL-1 of streptomycin diluted in water for 3 h. Both 
biofilms (C. albicans and S. epidermidis) were treated with 0; 0.001; 0.01; 0.1; 0.25; 
0.5; 1; 2.5; 5 and 10% w/v of NaN3, diluted in distilled water for 15 min. A total amount 
of 6 individual biofilms were prepared per each condition and treated either with 
antimicrobial drugs, aPDT or left untreated. 
5.2.10 Treatment of biofilms with aPDT 
5.2.10.1 Photosensitizers and light source 
The photosensitizer (PS) TMPyP was purchased from Sigma Aldrich (Taufkirchen, 
Germany), purity 97%. XF-73 was kindly provided by Destiny Pharma Ltd. (Brighton, 
UK). Both photosensitizers were dissolved in bidistilled water at a concentration of 500 
µM, passed through a 0.22 µm pore-size filter and stored at 4◦C until usage. Biofilms 
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were incubated with 100 µL (96 well microplates) or 500 µL (48 well microplates) of 
different concentrations of each of the PSs for 4 h in the dark at 37°C. The irradiation of 
samples were performed using an incoherent light source (UV236) λem = 418 ± 20 nm) 
provided by Waldmann GmbH (Schwenningen, Germany). The maximal fluence rate at 
the level of the irradiated samples was 13.4 mW cm-2. Biofilms were illuminated for 60 
min (48.2 J cm-2). A total amount of 6 individual biofilms were prepared per each 
condition and treated with the same aPDT parameters. Oxygen measurements were 
made before aPDT, and then each 20 minutes during aPDT (total treatment time 60 min: 
3 measurements) and once more 20 minutes after aPDT. 
Controls included: biofilms kept in the dark and not treated with PS (normal 
control); biofilms exposed just to the light (light control) and biofilms cells treated just 
with the PS (dark control). 
5.2.11 MTT assay (4,5-Dimethythiazol-2-yl)-2,5-diphenyltetrazolium 
bromide) 
It was evaluated the effect of XF-73-aPDT in S. epidermidis biofilms measuring 
biofilms metabolic activity directly by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-
tetrazolium bromide (MTT) test [202]. 
 
100 µL MTT solution (stock solution of 5 mg 
mL-1 in PBS, stored at -20 °C) was added to each well containing the treated/untreated 
biofilms. For blank values 10 µL MTT was added to 500 µL medium. After incubation 
for 14 h at 37 °C, 100 µl SDS solution (20%) was added to each well and plates were 
again incubated at 37 °C overnight. The absorbance of the produced formazan was 
recorded using an EMax endpoint ELISA microplate reader (Molecular Devices, 
California, USA) at 540 nm. The measured OD of the untreated controls was 
normalized to 1, which means a viability of S. epidermidis of 100%. 
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5.3 Results 
5.3.1 Biofilm formation 
Cells of C. albicans readily form biofilm in polystyrene microplates (section 2.2.2, Fig. 
16). Therefore a sensor was prepared using polystyrene as well. Like that, oxygen 
sensors were glued on the surface of 96 well microplates (surface area: 0.36 cm2) and C. 
albicans biofilms were formed on the surface of these sensors. Under these 
circumstances, C. albicans biofilms did not grow homogeneously and the biofilms were 
easily detached from the sensor surface without any experimental manipulations. 
Therefore it was not possible to achieve a reproducible and repeatable biofilm model on 
such an oxygen sensor foil (Fig. 45). 
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Fig. 45. C. albicans biofilms formed in 96 well polystyrene microplates coated with the 
oxygen sensitive sensor layer. The sensor was glued with high vacuum grease at the 
surface of the microplate wells and the biofilm was formed on its surface. Yellow arrow 
shows a well completely covered by the biofilm. Red arrow shows a well where the biofilm 
completely detached. Blue arrow shows a well partially covered by the biofilm 
In a next step the surface area was increased, so that the adherence of the C. albicans 
biofilms could be better monitored visually due to a larger surface area for cell 
attachment. Therefore, the sensors were placed in wells of a 48 well microplate (surface 
area: 0,76 cm2). Again, the biofilms were poorly adhered to the sensor surface and the 
biofilm was not evenly distributed over the total surface area (data not shown). 
It was tested whether the dye used as an indicator in the sensor or the glue used to 
attach the sensor to the microplate surface could influence cell adherence to the sensor. 
For this, cells were put on sensor spots with different concentrations of the dye and the 
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glue, but no attachment difference of the cells was observed using different 
concentrations of the dye as well as the glue. Furthermore to control if the heterogenous 
distribution of a growing biofilm on such a sensor foil is a common observation, S. 
epidermidis (ATCC-MYA-273) was used, a bacteria strain forming a more robust 
biofilm in polystyrene microplates when compared visually to C. albicans (ATCC-
MYA-273). S. epidermidis were able to form a biofilm directly on the sensor, which 
was homogenously distributed on the sensor foil, but when such a biofilm was washed 
to remove non-adherent bacteria, again the biofilm detached easily from the surface. 
5.3.2 Oxygen measurement with sensor located at the bottom of the 
biofilms formed in 48 well microplates 
5.3.2.1 Oxygen consumption of S. epidermidis treated with Penicillin-
streptomycin and sodium azide (NaN3) 
S. epidermidis biofilms grown on the sensor foil at the bottom of 48 well microplates 
were treated with Penicillin-streptomycin and NaN3 in order to establish the set up for 
optical monitoring of oxygen consumption by biofilms. The higher concentration used 
of Penicilin-Streptomycin (5000 units mL-1 and 5 mg mL-1) led to 50% of wells 
containing biofilms to stop consume oxygen. The lower concentrations (0, 1, 10, 1000 
and 5000 Units mL-1) did not cause any decrease in oxygen consuming. The higher 
concentration used of Penicilin-streptomycin (5000 units mL-1and - 5 mg mL-1) led to 
50% of wells containing biofilms to stop consume oxygen (Fig. 46). 
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Fig. 46. O2 measurement of S. epidermidis biofilms (24 h old) treated with different 
concentrations of Penicilin-streptomycin for 3 h. The optical sensor was placed on the 
bottom of the biofilm. 
When biofilms were treated with NaN3, 75% of the controls (biofilms not treated 
with NaN3) (Fig. 47) were not consuming oxygen. The data obtained does not show 
consistence because wells-biofilms treated with higher concentrations (0,1; 1 and 5%) 
of NaN3 were breathing more than when compared to the control biofilms. Again here, 
it was not possible that the biofilm covers homogenously and completely the surface 
area of the sensor foil. 
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Fig. 47. O2 measurement in S. epidermidis biofilms (24 h old) treated with different 
concentrations of NaN3 for 3 h. The optical sensor was placed on the bottom of the 
biofilm. 
Due to the situation that in both biofilm models a homogenous distribution of the 
biofilms on the sensor foil could not be established, the experimental set up was 
changed as follows: C. albicans biofilms were then formed directly on the bottom of 48 
well microplates and the sensor foil was placed on the top of the biofilm. 
5.3.1 Oxygen measurement with sensors located at the top of S. 
epidermidis biofilms 
Since the biofilms did not show optimal attachment to the sensor surface, the set up was 
changed. The biofilms were then formed directly at the bottom of the microplate well 
and the sensors were placed on the top of the biofilm. Experiments were done with 
intact biofilms and disrupted biofilms. The biofilms were disrupted with the tip of a 
pipette in order to investigate whether the EPS and the heterogeneous layers of the 
biofilms might interfere with oxygen measurements. 
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5.3.1.1 Oxygen consumption by S. epidermidis biofilms submitted to TMPyP-
aPDT 
The results obtained showed that control biofilms (not treated with PS and protected 
from the light) were breathing and breathing decreased 20% in the end of the treatment 
(Fig. 48 A). Dark control biofilms decreased breathing around 20% in the end of aPDT 
(60 min) and higher concentrations (0.1 and 1 µM TMPyP) did not cause any decrease 
in cell breathing. Biofilms submitted to aPDT (Fig. 48 B) showed decreased breathing 
proportional to increasing TMPyP concentrations. It was also observed that biofilms 
subjected to APDT started to breath less during the treatment. 
Besides measuring oxygen concentration of intact biofilms, it was also measured 
oxygen concentration with disrupted biofilms (Fig. 48, disrupted biofilm is marked with 
*) in order to check whether the biofilm structure (presence of EPS and heterogeneous 
layers of cells) affects oxygen measurement of the cells in the biofilm. When biofilms 
are disrupted, the sensor can get in contact directly with all bacterial cell layers, without 
interference of the EPS. In dark controls, bacteria from a disrupted biofilm, showed 
100% of breathing cells in all concentrations tested during all time periods, except when 
biofilms were treated with the highest TMPyP concentration (100 µM) (Fig. 48 A - 
purple column). At this concentration the oxygen consumption decreased by 20% at the 
end of treatment, but 20 min after treatment bacterial cells seem to recover (Fig. 48 A 
red column). The decrease in oxygen consumption detected by the sensor might be due 
to the fact that one control well had a biofilm which did not grow confluent (did not 
grow all over the well area). 
Disrupted biofilm cells showed to be more sensible to aPDT treatment than 
intact biofilms (Fig. 48 B). The increased susceptibility of disrupted biofilm cells to 
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aPDT may be due to the detachment of the cells from the wells made with the help of 
the tip of a pipette. Overall, these results show that biofilm cells kept in the dark were 
breathing more than cells submitted to aPDT. 
 
Fig. 48. Oxygen measurement in S. epidermidis biofilms non treated/ treated with TMPyP-
aPDT placing the sensor on the top of the biofilm. Measurements were made before aPDT 
starts (0 min), during aPDT (20; 40 and 60 min) and 20 min after aPDT. * indicates 
disrupted biofilm cells. The bars represent the mean value of 6 wells grown biofilm. 
5.3.1.2 Oxygen consumption by S. epidermidis biofilms submitted to XF-73-
aPDT 
Oxygen measurements of S. epidermidis biofilms did not show a difference between 
non-treated and treated aPDT biofilms (Fig. 49 A and B respectively). 
 
Fig. 49. Oxygen measurement of S. epidermidis biofilms non treated/ treated with XF-73-
aPDT placing the sensor on the top of the biofilm. Measurements were made before aPDT 
starts (0 min), during aPDT (20; 40 and 60 min) and 20 min after aPDT. * indicates 
disrupted biofilm cells. The bars represent the mean value of 6 wells grown biofilm., 
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After aPDT (80 min), the metabolic activity of S. epidermidis biofilms was 
measured by MTT assay (Fig. 50) and the results were compared with the oxygen 
measurements after 80 min of aPDT. Control biofilms showed high metabolic activity 
when compared to aPDT treated biofilms. APDT treated biofilms showed a decrease in 
metabolic activity proportional to the increase of XF-73 concentrations (Comparison 
Fig. 50×51). Oxygen measurements showed a correlation with MTT assay just with the 
smallest concentrations of XF-73 used (0 and 0,1 µM of XF-73). Higher concentrations 
did not show a good correlation, where the dark control biofilms were breathing less 
than the aPDT treated biofilms. The biofilms of these experiments showed a confluent 
grow in all the wells were they were formed. 
 
Fig. 50. Metabolic activity of S. epidermidis biofilms non treated/ treated with aPDT 
placing the sensor on the top of the biofilm. Measurements were made 20 min after the 
end of aPDT (80 min after the beginning if the treatment). The bars represent the mean 
value of 6 wells grown biofilms. 
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Fig. 51. Oxygen measurement in S. epidermidis biofilms non treated/ treated with XF-73-
aPDTaPDT placing the sensor on the top of the biofilm. Measurements were made 20 min 
after the end of aPDT (80 min after the beginning of the treatment).  The bars represent 
the mean value of 6 wells grown biofilms. 
 
5.3.2 Oxygen measurement with sensors located at the top of C. 
albicans biofilms 
5.3.2.1 Oxygen consumption by C. albicans biofilms treated with sodium azide 
(NaN3) 
C. albicans biofilms treated with NaN3 showed a decrease in oxygen consumption with 
increasing NaN3 concentrations (Fig. 52). 
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Fig. 52. Oxygen measurement in C. albicans biofilms treated with NaN3 placing the sensor 
on the top of the biofilm. Measurements were made 1 hour after the treatment. The bars 
represent the mean value of 6 wells grown biofilms ± standard deviation. 
5.3.2.2 Oxygen measurements of C. albicans biofilms submitted to TMPyP-
aPDT 
In the control treatment, intact biofilms were consuming more oxygen than disrupted 
biofilm cells (Fig. 53 A). The same happened when biofilm were submitted to aPDT 
(Fig. 53 B). Here again, the scraping of the biofilm from the microplate surface might 
have caused a little damage to the cells and this coupled with the action of aPDT caused 
a higher decrease in oxygen consumption when comparing intact and disrupted biofim 
cells.  
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Fig. 53. Oxygen measurement in C. albicans biofilms non treated/ treated with TMPyP-
aPDT placing the sensor on the top of the biofilm. Measurements were made before aPDT 
starts (0 min), during aPDT (20; 40 and 60 min) and 20 min after aPDT. * indicates 
disrupted biofilm cells. The bars represent the mean value of 6 wells grown biofilms. 
5.3.2.3 Oxygen measurements of C. albicans biofilms submitted to XF-73-aPDT 
Control biofilms were breathing under all PS concentrations and during the whole 
treatment (Fig. 54 A). With an exception of the control of the biofilm disrupted cells 
(0*), that showed a breathing reduction 20 min after the end of the treatment. This can 
be due to fact that 2 wells had no confluent biofilm growth or the tip of the pipette 
which was used to detach the cells from the well that killed the biofilm cells. Biofilms 
submitted to aPDT began to breathe less with increasing PS concentrations (Fig 54 B). 
Here, the higher PS concentration (100 µM XF-73) did not lead cells to reduce 
breathing, what can be explained by the shield effect caused by the excess of molecules 
of the PS in solution. 
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Fig. 54. Oxygen measurement in C. albicans biofilms non treated/ treated with XF-73-
aPDT placing the sensor on the top of the biofilm. Measurements were made before aPDT 
starts (0 min), during aPDT (20; 40 and 60 min) and 20 min after aPDT. * indicates 
disrupted biofilm cells. The bars represent the mean value of 6 wells grown biofilms. 
5.4 Discussion 
Biofilms are complex communities of microorganisms attached to surfaces and are 
encased in an EPS mainly composed of carbohydrates. They can be from 10 to 1000 
times more resistant to antimicrobial treatments than their planktonic counterparts. 
APDT can be a viable option to treat microbial cells resistant to the routinely used 
antimicrobial drugs since this treatment is based in the generation of singlet oxygen 
against which there is no cellular defense [21]. 
The presence and total concentration of oxygen in biological systems has a large 
effect on the behavior and viability of many cell types. Thereby, the integration of 
oxygen sensors within cell culture environments might be an efficient toll for 
monitoring of microbial cell survival  immediately after antimicrobial treatments, with 
any time delay, if a correlation between survival and the corresponding oxygen 
concentration is possible  [197]. In the section 2 it was showed that aPDT is a viable 
option to kill C. albicans biofilms. In this study, it was tried to establish a set up for the 
monitoring of C. albicans viability during and after aPDT by measuring oxygen 
concentration in the biofilms using a fluorescence-based sensor. 
The C. albicans strain used in this study is able to form biofilm in polystyrene 
microplates as already showed (section 2.2.2, Fig. 16). The sensors used in this study 
were made as well of polystyrene. Therefore it was expected that C. albicans would 
also form biofilms on the sensor surface, but they were not able to cover 
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homogeneously the complete surface of the well, covering just half or few parts of the 
sensor (Fig. 45). 
One hypothesis for the weak C. albicans attachment to the sensor may be the 
differences in the surface between the microplate and the sensor regarding roughness 
and physicochemical properties, like hydrophobicity and polarity. Microbial adhesion to 
surfaces increase as the surface roughness increases. This is because shear forces are 
diminished, and surface area is larger on rougher surfaces. Microorganisms also adhere 
better to hydrophobic and non polar surfaces than to hydrophilic materials [63]. On the 
other hand, S. epidermidis could grow over the entire surface of the well microplate, but 
biofilm adherence was not so stable when compared with the biofilms formed on the 
surface of polystyrene microplates, because handling of these biofilms during the 
treatment (washing steps and PS treatment) made them detach very easily from the well 
surface. 
In another set up, the biofilms were formed on the surface of the polystyrene 
microplates and after biofilm formation the sensors were placed on the top of the 
biofilms. The results achieved showed that overall, the sensor can detect differences in 
oxygen consumption between control biofilms and biofilms submitted to aPDT, but it 
was difficult to reproduce the results. When some wells were not completely covered by 
the biofilm, the results obtained showed that biofilms were not breathing. It is likely that 
the oxygen sensor could not distinguish oxygen consumption of a biofilm covering the 
complete well or juts part of the well. 
It was then compared, the sensibility of the sensor with a cellular metabolic 
activity assay (MTT assay). MTT assay showed that cell metabolic activity decreased in 
aPDT with increasing PS concentrations. However, the oxygen measurements obtained 
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with the sensor did not showed a showed a correlation with MTT assay just with the 
smallest concentrations of XF-73 used (0 and 0,1 µM of XF-73). 
The use of oxygen sensors to measure viability of cells in biofilms after 
antimicrobial treatment may be compromised by the fact that cells in deeper layers of 
biofilms might present oxygen depletion and enter in a dormant state [203]. The failure 
of oxygen to penetrate within the biofilm is not a physical exclusion. Water is the major 
component of the EPS (~97%), so that solutes that are the size of oxygen are able to 
diffuse in the EPS at a rate that is around 60% of the diffusion rate in pure water. 
Oxygen fails to penetrate and reach the cells located deep in the biofilm because it is 
respired by cells in the upper layers of the biofilm [204]. The size of the biofilm ranges 
from a few micrometers up to a few centimeters depending on the medium composition, 
the substrate nature and the strain. Areas located near the surface will be provided with 
both oxygen and substrate while deeper areas might present oxygen depletion and enter 
in a dormant state [205]. 
Furthermore, C. albicans and S. epidermidis are facultative anaerobes, which 
will grow aerobically in the presence of oxygen and fermentatively in the absence of 
oxygen. In this way, there are at least three distinct physiological states within a 
biofilm: 1) biofilm cells located in close proximity to the environment are in contact 
with both substrate and oxygen and will grow aerobically; 2) the layer below the aerated 
region will present just substrate and no oxygen, since oxygen will be the first 
metabolite to be depleted due to its moderate solubility in water; 3) deeper in the 
biofilm, it will be a region where both oxygen and substrate are depleted and microbial 
cells might become inactive and begin to die (Fig. 55) [203, 206]. Like that, there is a 
region within the biofilm, where oxygen is depleted, but metabolic activity is still 
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present and might be measured by MTT assay. This might explain why MTT assay was 
more sensible to measure biofilms viability than the oxygen sensor.  
 Another point would be that when the sensor was placed in the top of the 
biofilm, a small quantity of water was added on the top of the biofilm for better sensor 
attachment to the biofilm. The sensor could have measured also the concentration of 
oxygen in the water. Or the distance between the sensor and biofilm was too big and the 
overall volume of the well was gave false values. Overall, the results obtained in this 
study showed that the optical oxygen sensor could detect differences between biofilms 
not treated and treated with aPDT. 
 
Fig. 55. Cells within a biofilm: a) indicates active cells; b) indicates intermediate cells and 
c) dormant cells. Adopted and modified from reference [203]. 
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6 Summary 
Candida albicans is the main type of fungi able to form biofilms, which cause 
superficial skin and mucous membrane infections as well as invasive mycoses, 
particularly in immunocompromised patients. In these patients, invasive infections are 
often associated with high morbidity and mortality. Furthermore, the increase in 
antifungal resistance has decreased the efficacy of conventional therapies. The use of 
aPDT as an antimicrobial topical agent against superficial and cutaneous diseases 
represents an effective method for eliminating microorganisms. 
The first chapter describes: a) the complex problem of C. albicans infections, b) 
what a biofilm is, why they are so resistant to antimicrobial agents and their importance 
in infections. In addition the first chapter describes the antimicrobial Photodynamic 
Therapy (aPDT) and suggests it as an effective approach for killing of microbial cells. 
The second chapter shows for the first time the use of XF-73, a new porphyrine 
derivative, combined with blue light to inactivate C. albicans biofilms, causing 5 log10 
cell killing. The results were compared to TMPyP, an already known PS The efficacy of 
aPDT was also compared with the efficacy of Amphotericin B (AmB), the gold 
standard for the treatment of fungal infections. The presence of extracellular polymeric 
substance (EPS), which is a hallmark characteristic of microbial biofilms, was also 
detected. Besides, for the first time, singlet oxygen (1O2) was directly detected in 
biofilms treated by XF-73-aPDT. 
In chapter 3, a model of duo-species biofilm, formed by C. albicans and S. 
epidermidis, was developed. The susceptibility of C. albicans, co-aggregated in this 
duo- species biofilm, was evaluated using XF-73-aPDT. Duo-species biofilms were less 
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susceptible to XF-73-aPDT than monomicrobial C. albicans biofilms. The results 
showed that the susceptibility to aPDT decreases with the increase of the complexity of 
the biofilms composition.  
Since the over expression of heat shock proteins is a mechanism, whereby cells can 
become resistant to aPDT, in chapter 4 it was examined, whether the heat shock protein 
70 (Hsp70) over expression after thermal stress protects C. albicans cells against the 
oxidative damage caused by aPDT. In addition, it was investigated, whether C. albicans 
cells, treated by aPDT, might over express Hsp70. For this, the kinetics of Hsp70 
expression in C. albicans cells, treated with a sub lethal dose of aPDT, were determined 
over a period of 24 h. The results, obtained, showed that the over expression of Hsp70 
by C. albicans cells is not a mechanism, by which microbial cells might develop 
resistance to TMPyP-mediated aPDT. Also, the expression of Hsp70 in C. albicans did 
not increase after sub-lethal TMPyP-mediated aPDT. 
Chapter 5 reports the use of a luminescence based oxygen-sensitive sensor for 
monitoring oxygen concentration of C. albicans and S. epidermidis biofilms during 
aPDT. The knowledge of oxygen concentration during aPDT is important to improve 
the efficacy of aPDT. 
  
7 Zusammenfassung 115 
 
7 Zusammenfassung 
Candida albicans ist die wichtigste Pilzart, welche fähig ist, Biofilme zu bilden. 
Sie verursachen vor allem bei immunsupprimierten Patienten oberflächliche Haut- und 
Schleimhautentzündungen sowie invasive Mykosen. Bei solchen Patienten werden 
invasive Infektionen oft mit einer erhöhten Morbidität und Mortalität in Verbindung 
gebracht. Zudem hat die verstärkte antimykotische Resistenz die Wirksamkeit 
konventioneller Therapien verringert. Die Nutzung von aPDT als antimikrobielle 
Behandlung gegen oberflächliche Krankheiten und Hautkrankheiten stellt eine effektive 
Methode zur Eliminierung von Mikroorganismen dar. 
Das erste Kapitel beschreibt: a) die Problematik von C. albicans Infektionen, b) 
was Biofilme sind, warum sie so resistent gegen antimikrobielle Behandlungen sind und 
welche Bedeutung sie bei Infektionen haben. Zusätzlich wird im ersten Kapitel die 
antimikrobielle Photodynamische Therapie (aPDT) beschrieben und als eine effektive 
Methode zum Abtöten mikrobieller Zellen vorgestellt. 
Das zweite Kapitel zeigt erstmals den Einsatz des neuen Porphyrin Derivates 
XF-73 in Verbindung mit blauem Licht zur Inaktivierung von C. albicans Biofilmen, 
wobei eine Zellabtötung von 5 log10 erreicht wurde. Die Ergebnisse wurden mit 
TMPyP, welcher einen bereits bekannten Photosensitizer darstellt, sowie mit der 
Wirksamkeit von Amphotericin B (AmB), dem Standardmedikament für die 
Behandlung von Pilzinfektionen, verglichen. Es konnte außerdem gezeigt werden, dass 
die Existenz extrazellulärer polymerer Substanzen (EPS), welche eine zentrale 
Charakteristik mikrobieller Biofilme ist, einen Einfluss auf die Effizienz der 
Wirksamkeit von aPDT- und AmB-Behandlungen hat. Weiterhin konnte erstmals 
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Singulett-Sauerstoff (1O2) direkt in Biofilmen, welche mit XF-73-aPDT behandelt 
wurden, gemessen werden. 
In Kapitel 3 wurde ein Modell eines Biofilms, welcher aus C. albicans und S. 
epidermidis gebildet wurde, entwickelt. Die Empfindlichkeit der C. albicans innerhalb 
dieses Biofilms gegenüber XF-73-aPDT wurde evaluiert. Dabei zeigte sich, dass die 
Biofilme, welche aus diesen beiden Spezies bestanden, weniger empfindlich gegenüber 
XF-73-aPDT waren als monomikrobielle C. albicans-Biofilme. Die Ergebnisse zeigten, 
dass die Empfindlichkeit gegenüber aPDT mit steigender Komplexität der Biofilme 
abnimmt. 
Da die übermäßige Bildung von Hitzeschock-Proteinen ein Mechanismus ist, 
durch welchen Zellen resistent gegen aPDT werden können, wurde in Kapitel 4 
untersucht, ob das durch eine thermische Stresssituation induzierte Hitzeschock-Protein 
70 (Hsp70) C. albicans gegen die oxidative Wirkung der aPDT schützt. Zusätzlich 
wurde untersucht, ob C. albicans-Zellen, welche einer aPDT ausgesetzt werden, 
übermäßig Hsp70 bilden. Hierfür wurde der Verlauf der Hsp70-Bildung in C. albicans-
Zellen, welche mit einer subletalen Dosis aPDT behandelt wurden, für eine Dauer von 
24 Stunden bestimmt. Die Ergebnisse zeigten, dass die übermäßige Bildung von Hsp70 
durch C. albicans-Zellen kein Mechanismus ist, durch welchen die mikrobiellen Zellen 
eine Resistenz gegen TMPyP-aPDT entwickeln können. Auch zeigte sich durch die 
Behandlung mit subletaler TMPyP-aPDT keine vermehrte Bildung von Hsp70 durch C. 
albicans. 
Kapitel 5 beschreibt den Einsatz eines lumineszenzbasierten Sauerstoffsensors, 
durch welchen die Sauerstoffkonzentration in den C. albicans- und S. epidermidis-
Biofilmen während der aPDT gemessen werden kann. Das Wissen über die 
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Sauerstoffkonzentration während der aPDT ist wichtig, um in der Zukunft die 
Wirksamkeit der aPDT zu verbessern. 
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